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I. INTRODUCTION 
The use restrictions and tolerance levels established in the regis­
tration of an insecticide involve the selection of a value labeled as the 
human safety factor. Although the value attempts to accommodate a high 
degree of safety by the inclusion of such factors as 100-fold decreases in 
allowable levels, this does not necessarily guarantee a high degree of 
safety. This is particularly important for insecticides such as para-
thion, which, compared with others in the organophosphorus class, has a 
small margin between the no-effect level and the LD^g. Toxicity tests on 
mammals form the initial data base on which tolerance levels are estab­
lished for humans, and the closer the estimation of actual toxicity to 
humans, the more closely the tolerance level approaches a guaranteed human 
safety. 
In this regard, it is advantageous to characterize the fate of in­
secticides ^  vivo and the time dependency of their manipulation ^  vivo 
by: 
1. Seeking out biological parameters which more closely approximate 
minimum risk. 
2. Establishing closer links between sensitive animal systems used 
as barometers of safety and humans as victims of the risk. 
It is recognized (Schimassek et al., 1974) that the primary aim in the 
choice of method for any metabolic study should be to imitate vivo 
physiological conditions as closely as possible. The conditions of the 
cell, such as compartmentalization of metabolites or enzymes within 
organelles, are altered by in vitro techniques. Furthermore, data from 
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one technique are not sufficient, and must be compared with more complex 
conditions. 
The use of complex conditions is particularly critical in determining 
the metabolic disposition of insecticides. The partitioning of a foreign 
compound between blood and liver, as well as its rate of delivery and re­
moval (i.e., metabolic inactivation) are important factors in its rate and 
extent of disposition within the whole animal. Recent attention has 
focused on hepatic clearance (Wilkinson, 1975) and biotransformations of 
foreign compounds (Fingl and Woodbury, 1975) in consideration of disposi­
tion, concentrating primarily on nonsynthetic metabolic reactions (oxida­
tion, reduction, hydrolysis, dealkylation and desulfuration) and synthetic 
reactions (conjugation). 
These considerations of complex conditions and biotransformations 
have included insecticides, recognized as a class of potentially lethal 
toxins. Of particular note is parathion (0^,0-diethyl-2-nitrophenyl 
phosphorothioate) (vide Figure 1, page 6). Parathion is a highly lipid-
soluble liquid with a high vapor pressure. Its applications in agricul­
tural and urban practices are as a spray or dust, consisting of parathion 
adsorbed to an inert, finely particulate material. As a result, it has 
the potential of being absorbed through gastrointestinal, dermal, and 
inhalation routes. By itself, parathion's anticholinesterase activity is 
low; however, its primary metabolite, paraoxon (0^,0-diethyl-j0-£-nitro-
phenyl phosphate) (vide Figure 1), is much more active. Because of its 
lipid solubility, parathion is well-absorbed after dermal or oral expo­
sure, and has an ubiquitous effect at both peripheral and central cholino-
deptive sites by virtue of its ability to cross the blood-brain barrier in 
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a toxic form (Koelle, 1975). As a result of its toxicity (oral for 
male rat is 13 mg/kg), parathion has been responsible for more cases of 
accidental poisoning and death than any other organophosphorus compound 
(Murphy, 1975). 
The relationship between enzymatic metabolism and toxicity of para­
thion is extremely complex. Its toxicity depends on the net availability 
and ability of the biologically active compound to inhibit acetylcholin­
esterase at critical sites in the nerve tissue, and this in turn is de­
pendent on the dynamic relationship between activation and deactivation 
reactions. These are not always predictable from the results of measure­
ments of the relative rates of enzyme reactions ^  vitro, particularly 
since both activation and deactivation reactions are catalyzed by common 
enzyme systems with common cofactor requirements, tissue distribution and 
intracellular location (Murphy, 1975). 
In an effort to account for some of the inherent complexities in the 
qualitative and quantitative determination of parathion toxicity, it has 
been suggested (Schoenig, 1975) that perfusion of the intact liver be 
conducted to link up discrepancies between predominant pathways ^  vitro 
and i^ vivo. Isolated perfused liver preparations permit the study of the 
actions of hepatocellular enzymes on parathion in the intact organ. Such 
a study is recognized by others (Fuhremann et al., 1974), and is the topic 
of this dissertation. 
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II. LITERATURE REVIEIf 
A. The State of the Art 
1. Characterizing the metabolic disposition of parathion 
Upon absorption, parathion interacts with the blood. Studies by 
Skalsky and Guthrie (1975, 1977) revealed that incubation of parathion 
with whole rat blood resulted in approximately 80% binding to plasma con­
stituents, with 18% contained in the red cell cytosol. They suggested 
that plasma parathion was hydrophobically bound to nonspecific binding 
sites on plasma lipoproteins by a simple partitioning mechanism, and that 
the high solubility of parathion in the plasma fluid was due to its 
polarity. The suggested hydrophobic attraction of parathion to blood 
binding sites is consistent with the current concept of red cell membrane 
transport (Rothstein et al., 1976), which proposes specific and competi­
tive transport through the red cell membrane's anionic, proteinaceous, 
multicharged binding sites, preceded by hydrophobic barriers to limit 
free diffusion. A similar parathion blood distribution profile was ob­
tained by Schoenig (1975), who further elucidated that parathion did not 
break down into metabolites during a 45 minute incubation period in rat 
blood. Skalsky and Guthrie contended that because of the polar nature of 
parathion and the rapidity of its association/dissociation reactions with 
blood lipoproteins, its rate of partitioning to other tissues is rapid. 
These characteristics suggest that parathion is mobile ^  vivo, and is not 
subject to extensive deposition and immobilization in lipid stores. This 
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mobility would result in its exposure to the sieving action of and meta­
bolic biotransformation by the liver. 
Hepatic biotransformation mechanisms have been extensively investi­
gated (Appleton and Nakatsugawa, 1977; Fuhremann et al., 1974; Gaines 
et al., 1966; Ku and Dahm, 1973; Lichtenstein et al., 1973; Miyata and 
Matsumura, 1972; Nakatsugawa and Dahm, 1967; Nakatsugawa et al., 1968, 
1969; Neal, 1967a,b; Neal and DuBois, 1965; Pankaskie et al., 1952; 
Whitehouse and Ecobichon, 1975) and reviewed (Schoenig, 1975). These 
studies have revealed an ^  vivo metabolic manipulation of parathion via 
two pathways (Figure 1). 
The first pathway is a hydrolytic dearylation of parent parathion by 
aryl esterases or mixed function oxidases (mfo), utilizing NADPH and 
oxygen to form diethyl phosphorothioic acid (DEPTA) and 2rnitrophenol 
(PNP) as breakdown products (Neal and DuBois, 1965; Nakatsugawa et al., 
1969). The mfo are enzymes of the microsomal fraction, located on the 
smooth endoplasmic reticulum. The second pathway involves desulfuration 
of parathion to produce the active metabolite, paraoxon. This in turn 
undergoes 0-dealkylation to form desethyl paraoxon (DEP) (Whitehouse and 
Ecobichon, 1975; Neal, 1967a,b; Ku and Dahm, 1973) or dearylation to form 
diethyl phosphoric acid (DEPA) and PNP (Ku and Dahm, 1973), followed by 
0-dealkylation to monoethyl phosphoric acid (MEPA). 
The balance of activative and degradative pathways is a critical de­
terminant of the action of parathion. This balance is not a simple ratio 
of the two pathways indicated in Figure 1 vivo, but is dictated by the 
physiological organization of the body. The elucidation of the influence 
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Figure 1. Mammalian degradation of parathion in vivo 
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of this physiological organization is currently in a state of investiga­
tive evolution. In the process, the following facts regarding the path­
ways of parathion metabolism have been revealed; 
1. Parathion degradation to DEPTA occurs mainly in the liver micro­
somal fraction as a result of mfo action (Ku and Dahm, 1973; 
Real, 1967a). 
2. Desulfuration of DEPTA is very low in vivo (Nakatsugawa et al., 
1969). 
3. More than one enzyme is involved with desulfuration of parathion 
(Nakatsugawa et al., 1969). One of the principle enzymes is 
glutathione-SH transferase (Appleton and Nakatsugawa, 1977). 
4. Urinary metabolites of parathion in rats are, in descending quan­
tities, DEPTA > inorganic sulfate > DEP > DEPA > MEPA > phos­
phoric acid (Nakatsugawa et al., 1969). In cows, oral dosing 
with parathion does not produce detectable parathion, PNP or £-
aminophenol in blood, milk or urine (Pankaskie et al., 1952). 
The authors suggested that PNP is reduced to £;-aminophenol and 
then excreted in the urine as a glucuronide conjugate. 
5. The rate of paraoxon formation from parathion in an in vitro 
homogenate preparation decreases with time over a one hour period 
(Whitehouse and Ecobichon, 1975; Neal, 1967a). 
6. PNP is produced from parathion in microsomal preparations, not 
from paraoxon (Nakatsugawa and Dahm, 1967; Nakatsugawa et al., 
1968). In vitro, this reaction is as extensive as activation of 
parathion to paraoxon. 
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7. Liver microsomes are the only effective in vitro preparation 
able to induce paraoxon degradation. Other tissues (lung and 
blood > kidney > spleen, pancreas, heart, muscle, brain, small 
intestine, large intestine) are able to induce paraoxon degrada­
tion no more than 10% that of the liver (Ku and Dahm, 1973; 
Nakatsugawa et al., 1969; Appleton and Nakatsugawa, 1977; Neal, 
1967a). 
8. NADPH-dependent D-dealkylation of paraoxon to form DEP and MEPA 
occurs both ^  vitro in microsomal preparations and ^  vivo in 
the rat (Ku and Dahm, 1973). 
9. The major routes of paraoxon metabolism in the rat are to water 
soluble DEP, DEPA, MEPA and an amino acid conjugate (Ku and Dahm, 
1973). 
10. Enzymes from the soluble portion of liver homogenates (nonmicro-
somal) can affect glutathione-SH-dependent deethylation of para­
oxon to form DEP, although the major site of this conversion is 
in the microsomal fraction (Appleton and Nakatsugawa, 1977). 
11. Liver and plasma contain esterases that can be phosphorylated 
by paraoxon. This suggests that phosphorylation of proteins is a 
determinant in paraoxon toxicity (Appleton and Nakatsugawa, 
1977). 
Several corollaries can be distilled from these findings. Although 
the parathion activating enzymes are concentrated in the liver, the evi­
dence indicates a detoxifying rather than an activating function of the 
liver. Therefore, the potential effect of parathion activation in the 
liver is nullified by the excess capacity of the liver (and lung and 
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serum) to hydrolyze paraoxon. Activation by extrahepatic tissues may also 
play an important role in the expression of parathion toxicity. Further 
evidence of a high capacity for paraoxon metabolism is derived from the 
fact that mfo metabolism occurs mainly in the centrilobar regions of the 
liver (Appleton and Nakatsugawa, 1977), whereas proliferation of the 
microsome-containing smooth endoplasmic reticulum caused by chemical in­
ducers involves cells in the periportal regions as well. The significant 
induction of deethylase ^  vitro by chemical inducers may be in nonde-
ethylating regions of the liver, and deethylase activity vivo may be 
greater in extrahepatic tissues, masking the hepatic pattern. The appar­
ent importance of paraoxon deethylation ^  vivo, coupled with the insta­
bility of DEP, is not consistent with the low ratio of paraoxon deethyla­
tion: deary lation ^  vitro, and the dependence of paraoxon dearylation on 
phosphatases suggests that phosphatases are overrepresented ^  vitro. 
Phosphatase action vivo is a cooperative event of a heterogeneous 
population of several enzymes with a collectively different ^  vivo sig­
nificance (Appleton and Nakatsugawa, 1977), and physical isolation of 
these enzymes in cells may not allow all to participate in paraoxon 
metabolism ^  vivo. In the blood, the importance of deethylating enzymes 
is more obscure. Even though the blood has a greater chance to deethylate 
paraoxon than parathion on the way to the liver, the deethylation:dearyla­
tion ratios are similar for both compounds in the blood (Appleton and 
Nakatsugawa, 1977). It may be that the toxicological significance of 
blood esterase lies in the fact that paraoxon blood levels are low, there­
by alleviating the necessity for a higher deethylation:dearylation mecha­
nism to detoxify paraoxon. 
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Vital to the detoxification of parathion is its conjugation and 
elimination. Glucuronidation by hepatic microsomes has been suggested 
(Pankaskie et al., 1952) as the excretory pathway for ^ -aminophenol, a 
reduction product of PNP derived from parathion hydrolytic dearylation. 
Several nonmicrosomal conjugation mechanisms are known to be active in 
drug metabolism (Fingl and Woodbury, 1975), such as acetylation, pseudo-
cholinesterase, glycine, glutathione and sulfate conjugations, 0^-, and 
N-methylation, and ribonucleoside and ribonucleotide conjugations. These 
mechanisms may be involved in the elimination of parathion and its metabo­
lites. 
2. Pharmacologic effects of parathion 
Parathion acts by interaction with a specific but widespread re­
ceptor, which serves functions common to most cells. The no-effect level 
in man is estimated to be 0.05 mg/kg/day at an average daily intake of 
0.005 mg/kg (Murphy, 1975). Parathion is an anticholinesterase agent, 
binding tightly to the esteratic sites of acetylcholinesterase. The pri­
mary target sites are all cholinergic nerve endings of preganglionic 
autonomic fibers, all postganglionic parasympathetic fibers, a few post­
ganglionic sympathetic fibers, all somatic fibers and central nervous 
system fibers. Parathion has the potential to produce the following 
pharmacological effects (Koelle, 1975): 
1. Cholinomimetic action of the muscarinic type at autonomic 
effector organs. 
2. Stimulation, followed by depression or paralysis of all autonomic 
ganglia and skeletal muscles. 
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3. Stimulation and subsequent depression of cholinoceptive sites of 
the central nervous system. 
The susceptibility of the mammalian organism to poisoning with these 
effects depends on the rate at which paraoxon is made available to inhibit 
acetylcholinesterase (i.e., acetylcholinesterase inhibition depends on the 
relationship between rates of parathion activation to paraoxon and degra­
dation of paraoxon. Both of these functions are carried out principally 
in the liver). 
Further insult is added to the toxicological effects of parathion by 
the aging phenomenon (O'Brien, 1976; Murphy, 1975). The tightening of the 
organophosphate-acetylcholinesterase bond, resulting in increased re­
sistance to therapeutic reversal agents, was demonstrated by Hobbiger 
(1955) and Berends et al. (1959). Support for this mechanism existing in 
parathion intoxication was provided by Appleton and Nakatsugawa (1977), 
14 14 
who noted an appearance of CO^ after dosing rats with C-ethyl para­
thion. 
There is clearly an interdependence between the pharmacological ac­
tion of parathion and the rates of activating and deactivating reactions. 
The critical importance of the rate phenomena is embodied in the speed of 
events at the target sites and at metabolic sites (i.e., the time required 
to reduce paraoxon below and elevate it above its threshold level for 
effect at cholinergic nerve junctions, the slow speed of reversing para­
oxon binding to acetylcholinesterase, the antagonistic effect of aging 
which further decreases the speed of binding reversal, and the rates of 
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clearance of parathion and paraoxon by the liver). The characteristics 
and underlying principles of liver clearance are discussed on pages 17-19. 
3. Models characterizing the metabolic disposition of parathion 
With the rising Importance of metabolic studies of Insecticides over 
the last two decades has come a developing sophistication of vitro 
analytical procedures to study complex situations more accurately. These 
procedures have evolved from single system metabolizing units to blood-
enriched whole organ metabolizing units. 
a. Primary system - a single system metabolizing unit Isolated 
hepatic enzyme systems are important in the elucidation of metabolic path­
ways of parathion, as exemplified by the findings on pages 7 and 8. In­
vestigations have been conducted on the microsomal fraction and the non-
micro somal fraction (enzyme systems soluble in the supernatant portions of 
cellular fractionations). The microsomal enzyme systems catalyze 
glucuronidatlon, oxidation, reduction, and hydrolysis reactions. Cyto-
chrom is a primary component of the microsomal oxidative pathway, as 
are the NADPH/O^-dependent mixed function oxidases, which are Involved 
with N- and 0-dealkylation, N-oxldation and hydroxylation, ring and side 
chain hydroxylations, sulfoxide formation, deamlnation and desulfuratlon. 
The nonmicrosomal (soluble) fraction is largely responsible for a variety 
of conjugations, in addition to hydrolytic, oxidative and reductive reac­
tions. 
Studies by Whltehouse and Ecobichon (1975) Indicated that microsomal 
mixed function oxidase activity is not saturated at a parathion incubation 
concentration of 2 x 10 (580 ppm). Investigations by Lichtensteln 
et al. (1973) and Neal and DuBols (1965) Indicated that rat liver micro-
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somal enzymes do not convert parathion to water soluble metabolites except 
for a small quantity of PNP. Paraoxon, on the other hand, is converted to 
PNP and ^ -aminoparaoxon. Nakatsugawa et al. (1969) further characterized 
DEPTA as a product of microsomal parathion metabolism. 
The 15,000 ^  supernatant fraction of a rat liver homogenate converts 
both parathion and paraoxon to water soluble metabolites, the former to 
aminoparathion and paraoxon (Lichtenstein et al., 1973). The presence of 
a reduced glutathione-dependent dealkylating enzyme in the soluble frac­
tion, capable of converting parathion to DEPTA, was shown by Nakatsugawa 
et al (1968) and Miyata and Matsumura (1972). 
Beyond the basic mechanism disclosure, isolated enzyme systems have 
as drawbacks that (1) they are liberated breakdown components of intact, 
compartmentalized cell systems, leading to the unnatural production of 
intracellular metabolites and (2) studies using these systems usually 
involve parathion loading to produce a "homogenate effect," that is, high 
substrate exposure to enzymes, risking saturation and swamping of some 
metabolic pathways (Schimassek et al., 1974). 
b. Secondary system - ^  complex metabolizing unit Techniques 
which fall into this category (isolated cell suspensions and liver slices) 
attempt to preserve the integrity of the cell structure, so that its con­
tents and their compartmental distribution within the cell are not quanti­
tatively or qualitatively disrupted. The unit of interest is the cell. 
Although this technique is used widely for the study of biochemical proc­
esses, it has not gained much acceptance for the study of xenobiotics. 
This is particularly true for liver slices, which release enzymes into the 
incubation medium to react with accumulating, nonexchangeable substrates 
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(Schimassek et al., 1974), and in which the essential components of 
metabolism become impaired on slicing (Rrebs et al., 1974). Isolated 
cell suspensions have proven to be more adaptable to problems of membrane 
function, xenobiotic action and cell metabolism (Berry and Werner, 1974; 
Krebs et al., 1974), although problems with proteolysis and leakage of 
substrates and ions into the medium have arisen (Krebs et al., 1974). 
These malfunctions are thought to be the result of changes in the cell 
membrane potential from the in vivo value (Lautt, 1976) and alteration of 
ATP level maintenance (Sestoft and Fleron, 1974). 
c. Tertiary system - whole organ metabolizing unit The liver is 
the primary filtering organ, and is critical to survival because of its 
life-sustaining metabolic functions (Shoemaker and Elwyn, 1969)—anhepatia 
leads to death by toxemia. Research has focused on liver viability 
parameters, and studies on biochemical and pharmacological effects in the 
isolated whole organ perfusion preparation have relied on these viability 
parameters. In contrast to the primary and secondary systems described 
earlier, whole liver perfusion preparations allow differentiation between 
reactions which are entirely hepatic from reactions which are manifest in 
the liver but secondary to those from extrahepatic sources. They permit a 
greater range of concentrations of perfusate constituents without exerting 
undue physiological effects, and therefore are suited to acute as well as 
subacute studies of poisons at levels which result in detectable quanti­
ties of metabolites (Shoemaker and Elwyn, 1969; Garattini et al., 1973). 
The functional unit of the liver, the lobule, is divided into three 
functional zones: (1) periportal (next to the portal canal), (2) inter­
mediate and (3) central (next to the central canal) (Elias, 1953). The 
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liver has a quasi-crystalline structure, with the input and output points 
of each lobule symmetrically arranged: all sinusoidal entrances and exits 
are adjacent, so that flow in adjacent sinusoids is concurrent. There is 
no opportunity within the lobular structure for diffusible materials to 
shortcircuit the vascular pathway and exit prematurely (Goresky, 1974). 
The sinusoidal vascular system within each lobule divides into an im­
perfect manifolding web, each split in the manifold feeding groups of 
cells (Winkler et al., 1974). Goresky (1964) determined that the lining 
of the sinusoids lacks the periendothelial cells present in most capillary 
walls, so that the hepatic counterpart of the capillary model proposed by 
Yudilevich (1970) contains a very loose double barrier (endothelium and 
basement membrane) separating the sinusoidal fluid from hepatocytes. 
Goresky and Bach (1970) further disclosed that the extravascular space 
surrounding hepatocytes is immediately accessible to substances dissolved 
in the vascular fluid. This underscores the functional importance of the 
morphological observation that the connective tissue lining the portal 
canal is reduced to a thickness of one cell punctured by holes at the 
sinusoidal level (Elias, 1953). 
In consideration of the whole organ, the liver consists of a large 
number of parallel lobular units, each with its metabolic enzymes uni­
formly distributed in a sheet of parenchymal cells. For substances sub­
ject to uptake and metabolic alteration by the liver, there is a length­
wise concentration gradient from the portal vein, through the sinusoids, to 
the collecting central vein. This is produced by unidirectional flow 
through the sinusoids and the uniform enzymatic activity of the hepato­
cytes (Goresky et al., 1973; Winkler et al., 1974). Studies on the 
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transsinusoïdal diffusion process have revealed that (1) transfer of 
materials from the sinusoids to the extravascular fluid compartment de­
pends on the transit time of that substance through the length of the 
sinusoids (Goresky and Rose, 1977), (2) transsinusoidal exchange is either 
by bulk filtration through the pores of the sinusoidal wall or diffusion 
into the extravascular fluid down a concentration gradient (Chinard et 
al., 1955) and (3) flow in the sinusoids is slow (i.e., hepatic exposure 
time is long), and therefore diffusible substances readily equilibrate in 
the lateral direction along the length of the sinusoid (Goresky and Bach, 
1970). Transsinusoidal diffusion into the extravascular space is assumed 
to take place so rapidly in a direction perpendicular to the direction of 
flow, that the concentrations of soluble substances inside the vascular 
compartment and extravascular compartment are considered equal (i.e., 
equilibration of soluble substances is so rapid in relation to flow that 
it is virtually complete along the length of the sinusoid). The sinu­
soidal wall is not a phase boundary of any consequence for dissolved 
materials (Chinard et al., 1955; Goresky, 1963). 
These concentration gradient and diffusion phenomena affect the 
hepatic clearance, rates of metabolism and venous outflow profiles of 
substances passing through the portal system. Good portal flow is used as 
an indication of a good ex vivo perfusion preparation (Schimassek et al., 
1974). Over a fourfold range of flows (840-3720 ml/min/kg) the liver is 
uniformly perfused, and there is no recruitment of new sinusoids within 
this range (Goresky et al., 1973). Flow regulation and distribution among 
all sinusoids ^  vivo is complex; it depends on nervous control and 
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hormonal control, as well as pressure on the liver surface and hepatic 
veins during the respiratory cycle (Winkler et al., 1971). The optimal 
hepatic flow rate for TnaviTmnn oxygen uptake and minimum vascular resist­
ance in pig livers vivo was determined to be 1 liter/min/kg liver. 
This was also the total ^  vivo flow rate through the portal vein and 
hepatic artery, although portal venous flow was lower and hepatic aterial 
flow higher (Winkler et al., 1971). Eiseman (1966; 1967) found 500 ml/ 
min/kg to be the optimal flow rate for maximum oxygen consumption in iso­
lated pig livers fed through the portal vein only. 
Pressure applied to one of the two afferent systems (portal venous 
and hepatic arterial) does not affect flow in the other system. This is 
because vascular tone in the liver is negligible, so that it acts as a 
passive sponge flooded by the two vessels. However, at extremely high 
pressures Glisson's capsule surrounding the liver has a confining effect 
on liver compliance, causing an increase in interstitial pressure (Eiseman 
et al., 1963). Increased hepatic venous pressure will cause passive en­
gorgement of the liver with perfusate. Lautt (1976) produced an increase 
of 20 ml/100 g in 2 min with an increased venous pressure of 9.35 mm Hg. 
Lindros (1974) also noted fluid accumulation at pressures of 5-10 cm 
water, with a 50% increase in extracellular fluid volume. Such effects 
will create a large error in the determination of tissue concentrations of 
metabolites which have a concentration gradient across the cell membrane. 
The importance of flow and the effects of pressure on flow are mani­
fested in hepatic clearance (the volume of blood from which a substance is 
removed by the liver per unit time) and venous outflow profiles of sub­
stances passing through the liver. The ^  vivo quantification of foreign 
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compound metabolism determined from the terminal plasma concentration or 
urinary excretion/time profiles is dependent on the parent compound's 
distribution and elimination. This means that hepatic clearance is im­
portant as a measure of the physiological efficiency of the liver. In ex 
vivo perfusion preparations to determine hepatic clearance, the faster the 
perfusate flow rate, the less the clearance of a foreign compound by the 
liver (Wilkinson, 1975).^ 
For a foreign compound passing through an ^  vivo perfusion prepara­
tion, the venous outflow profile has two parts: (1) throughput - material 
which never entered the hepatic cells, but was propagated along as a 
moving wave in the sinusoids adjacent to the hepatic cell surface, and (2) 
return - material which entered the hepatocytes, escaped metabolic altera­
tion, returned to sinusoidal circulation and emerged at the outflow. 
Addition of a foreign compound to the portal perfusate of an ex vivo per­
fusion preparation as a pulse will produce its pulsatile appearance as a 
wave on the venous side. Concomitant addition of a substance known to 
remain within the vascular channels (i.e., one which will not diffuse into 
the extravascular space) will also result in its pulsatile appearance on 
the venous side. The degree of lateral diffusion of concomitantly inject­
ed substances, along with variation in flow and the architecture of the 
lobule, will produce pulsatile outflow waves of varying widths. Outflow 
profiles of a variety of substances, as well as their resolution into 
^The flow rate/clearance relationship is a function of (1) parti­
tioning of the foreign compound into the liver, (2) the size of the liver 
and (3) the intrinsic rate of metabolism by biochemical processes. 
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throughput and returning material components have been explored by Goresky 
(1974), Goresky and Bach (1970) and Goresky et al. (1973), as typified in 
Figure 2. In the upper plot of the figure, D-galactose undergoes diffu­
sion from the sinusoids to the extravascular space, uptake by hepatocytes 
and metabolic sequestration or return to sinusoidal circulation. The 
^^Cr-labeled red blood cells are confined to the vascular space. The 
lower plot is a semilogarithmic expansion gf.^he D-galactose outflow pro­
file, resolved into throughput and returning material components. Passage 
of substances across the hepatocyte membrane (or lack of it) is heavily 
influenced by carrier-mediated transport phenomena that extend beyond the 
scope of this review. 
The metabolic sequestration process for a xenobiotic such as para-
thion involves its removal from the sinusoid?.! perfusate by hepatocytes 
with subsequent alteration (detoxification, conjugation or binding). 
Addition of a small quantity of a xenobiotic to the portal perfusate will 
result in the bulk of it being taken up by the hepatocytes, with a small 
amount of it passing through as throughput. Addition of successively 
higher quantities to the portal perfusate will eventually saturate the 
hepatocyte uptake and/or alteration process, continually causing a rise in 
the returning and throughput components of the hepatic venous outflow 
profiles. Past the sequestration saturation level, the throughput compo­
nent is high enough for full potency of the xenobiotic to exist (Goresky, 
1974). In the case of parathion, this phenomenon is particularly impor­
tant, since (1) the perfusate binding mechanism which prevents paraoxon 
activity at nerve junctions will become quickly saturated and (2) the 
20 
0 Cr- rbc 
- D-Galactose 
E 
c 
o 
o 
2 
I 
3 
o 
X 
1 
20 
Figure 2. Hepatic venous outflow profiles of D-galactose and Cr-labeled 
red blood cells (added as a pulse to the portal perfusate of an 
ex vivo liver perfusion preparation. Details of the two plots 
are described in text. The lower plot is a semilogarithmlc ex­
pansion of the D-galactose outflow profile, resolved into 
throughput and returning material components (Goresky, 1974)) 
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titer of parathion in the perfusate has a potential for supplementing the 
toxic effects of paraoxon produced by desulfuration in the liver, by 
virtue of fewer competitive binding sites being available, leaving more 
paraoxon in the free form. 
In this tertiary system (the whole organ metabolizing unit), the 
introduction of new dimensions into metabolism by perfusion (flow, pres­
sure, concentration and bile effects, saturation and barrier phenomena, 
membrane transport, tissue viability, liver morphological influences, 
compartmentalization into vascular, extravascular, intracellular and sub­
cellular components) alters the kinetic characteristics of parathion 
metabolism. Pure Michaelis-Menten mechanisms in the ^  vitro system 
(single system metabolizing unit) are represented by straight lines on 
Lineweaver-Burk plots. For the perfused liver, the plots are curvilinear, 
as illustrated by the model plot in Figure 3 (Winkler et al., 1974). 
The parameters defining the Lineweaver-Burk plot (K^ and V^^^) for 
intracellular sequestration in the whole organ preparation are different 
from the vitro values by virtue of membrane phenomena and the stepdown 
in concentration of the substrate across the cell membrane at each point 
along the sinusoid. The concentrations thus used to determine K and V 
m max 
are average lobular concentrations (Goresky et al., 1973). This point was 
found to be the case for phenazone metabolism by the perfused pig liver 
(Andreasen et al., 1977), where the and values were higher than 
those obtained from microsomal studies. Furthermore, rates of influx and 
efflux of compounds from hepatocytes (Goresky, 1974), along with their K 
in 
values, have Indicated that metabolic sequestration occurs at levels far 
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Figure 3. Lineweaver-Burk model plot for ^  vitro liver microsomal and 
ex vivo whole liver metabolism of substrates. C = average 
sinusoidal substrate concentration; V = velocity of the meta­
bolic reaction as indicated by the appearance of product per 
unit time (Winkler et al., 1974) 
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below those which saturate the transport process (i.e., the limiting 
factor is carrier-mediated hepatocyte uptake through the membrane). 
d. Quaternary system - blood perfused whole organ metabolizing unit 
The tertiary model described in the preceding section encompasses the com­
plex parameters of three-dimensional dynamism that characterize events in 
the complete liver. The common link between what is a detached artificial 
system (isolated whole liver perfused with an artificial medium) and an 
in vivo study is the blood perfused whole liver. This allows all of the 
parameters of transport, exchange and diffusion phenomena to exist, with 
the addition of what is the ^  vivo contact medium. While this metaboliz­
ing unit isolates the liver from the masking effects of other ^  vivo 
functions, the presence of two tissues in the artificial system creates 
four possible interactions for parathion and each of its metabolites; (1) 
insecticide-blood interactions, (2) insecticide-liver interactions, (3) 
blood-liver interactions and (4) insecticide in blood-insecticide in liver 
interactions. This system defines a five-compartment model (plasma, red 
blood cells, extracellular fluid, intracellular fluid and bile) with the 
associated formula work typified by Skinner et al. (1959) in their three-
compartment model. Parathion metabolism, blood distribution and binding 
phenomena described on pages 4-10 of this dissertation apply to the 
quantemary system, in addition to the following points: 
1. The state of liver viability affects the titer of normal blood 
constituents. Tonnesen (1976) demonstrated that porcine hepatic 
anoxia causes elevated levels of serum alkaline phosphatases and 
aminotransferases. The importance of phosphatases as hydrolytic 
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esterases of parathion and paraoxon has been illustrated (Ku and 
Dahm, 1973; Appleton and Nakatsugawa, 1977). 
2. Folke (1974) has suggested that the high metabolic rate of the 
liver vivo is determined and maintained by a humoral factor 
in the blood which is destroyed after a short period of isolated 
perfusion of the liver in a closed system with recirculating 
blood. This is denoted by a drop in oxygen consumption by the 
organ. 
3. Blood flow through the liver sinusoids is by bolus flow. The red 
blood cells almost completely fill the lumen, and at velocities 
encountered in the sinusoids, the red cells do not allow a layer 
of plasma to slip by. The red cells push along between them 
discrete segments of plasma in which mixing occurs. This mixing 
action increases the rate of presentation of diffusible sub­
stances to the extravascular space as a result of the absence of 
a sinusoidal permeability barrier (Goresky and Bach, 1970). By 
contrast, cell-free media, such as those used in the tertiary 
system, are subject to laminar flow, creating a different pattern 
of lateral diffusion of dissolved substances. The mean sinu­
soidal transit time for a red cell is ca. 5.35 sec; for a sinu­
soidal length of 0.5 mm, the linear rate of passage of a red cell 
in the exchange area is 93 y/sec. The slow linear rate of blood 
flow in comparison to the rate of diffusion equilibration is the 
basis for flow-limited distribution of substances into the extra­
vascular space (vide supra, pages 15 and 16). For substances 
contained in the red cells, such as xenobiotics, their équilibra-
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tion between red cell and extravascular space requires that the 
flow transport the red cell only a small distance during the 
half-time of exchange. The diffusible substance in the red cell 
which does not equilibrate completely will appear more quickly in 
the outflow than one which does. Those substances appearing more 
quickly at the outflow will be related to the size of the slowly 
exchanging red cell sink (i.e., the hematocrit) (Goresky, 1963). 
4. The binding of parathion to plasma proteins has the following 
characteristics and consequences; 
a. The binding is a protective mechanism for isolating parathion 
from the site of action and preventing its metabolic activa­
tion or degradation. 
b. The weak nature of its binding allows it to freely dissociate 
and therefore readily penetrate tissues. 
c. Nonhepatic tissues ^  vivo obtain low-density lipoproteins by 
receptor-mediated pinocytosis through the cellular membrane. 
Binding of parathion to low-density lipoproteins presents it 
with direct access to the cell, bypassing the membrane. 
These binding phenomena can lead to a decreased clearance of 
parathion by the liver if the degree of binding is great. Alter­
natively, clearance may be increased because binding agents are a 
delivery system, bringing parathion from other sites to the liver 
and readily dissociating from it. The relationship between 
parathion binding and its hepatic clearance is curvilinear as a 
result of its extensive binding (Shand et al., 1976). Studies 
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have suggested (Lauwerys and Murphy, 1969a,b) that binding de­
creases the toxicity of paraoxon by reducing its exposure to 
target sites, the plasma protein binding agent acting as a buffer 
against paraoxon toxicity by keeping free levels in blood low. 
Schoenig (1975) further suggested that blood binding of paraoxon 
may explain the discrepancy between high in vivo values of DEPTA 
(a direct metabolite of parathion) and high in vitro microsomal 
values of DEPA (a direct metabolite of paraoxon). 
B. The Perfusion System 
In all perfusion preparations, there is a gradual deterioration of 
hepatic function beginning at the onset of perfusion (Shoemaker and Elwyn, 
1969). The objective of the artificial support system for the organ is to 
suppress the onset and rate of deterioration as much as possible. The 
basic hardware of an artificial system consists of a pump, oxygenator, 
heat exchanger, perfusion medium reservoir, liver chamber, flow probe, 
temperature probe, pressure port and perfusate sampling port. The soft­
ware consists of the liver and its circulating medium. The choice and 
design of system hardware and software have been extensively reviewed 
(Ross, 1972; Ritchie and Hardcastle, 1973). 
For the isolated pig liver perfusion, a variety of materials have 
been used in the system's hardware, predominantly glass, stainless steel, 
silicone rubber, methyl methacrylate (Lucite®, Plexigla^, Perspex®) and 
polyvinyl chloride tubing. Components of the recirculating system have 
been placed in a variety of orders and the liver in a variety of chamber 
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designs (Abouna, 1968; Eiseman, 1967; Eiseman et al., 1961, 1970; Kestens 
and Lambotte, 1973; Linzell et al., 1971; Mieny and Eiseman, 1968; Norman 
et al., 1966a; Winkler et al., 1971). Investigations on ail components of 
the artificial system have underlined the importance of optimal blood flow 
and blood pressure, as governed by the pump and design of the system in 
general. Winkler et al. (1971) determined ûa vivo portal and hepatic ar­
terial flow rates to be 660 ml/min and 270 ml/min respectively for livers 
averaging 1350 g in weight. Artificial perfusion of the ^  vivo livers by 
the portal vein only was optimal at a blood flow rate of 950 ml/min. In 
vivo and ^  vivo portal pressures were 16 mm Hg and 11 mm Hg respectively, 
and hepatic venous pressures were 6 mm Hg for both types of preparations. 
High afferent pressure was a requirement for good blood flow, 10 cm water 
being the critical closing pressure for the portal system, 40-160 cm water 
causing a proportional increase in liver resistance and weight. In a 
system used by Eiseman (1966), a hepatic venous pressure increase from 
-5 mm Hg to +10 mm Hg caused an increase in the rate of ascites fluid 
secretion from 5 ml/min to 18 ml/min. With an artificial respiratory 
cycling rate of 15 cycles/min hooked up to the system, optimum oxygen 
utilization was achieved with a negative pressure of -10 mm Eg and posi­
tive pressure of +5 mm Hg. In a different system (Eiseman, 1967), a per­
fusate temperature increase or decrease from 38®C caused a deviation from 
optimal metabolic efficiency of the liver. 
A variety of perfusion media have been used, ranging from ionic 
solutions, through red cell suspensions in ionic media, to autologous 
whole blood (Ross, 1972). The choice of blood as a perfusion medium is 
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largely dictated by the availability of autologous, homologous and 
heterologous blood in sufficient quantities to prime the perfusion hard­
ware, and by the nature of the study. The medium is the lifeline between 
the mechanical support apparatus and the liver, carrying oxygen and 
nutrients to the organ, removing metabolites and carbon dioxide, and 
maintaining homeostatic temperature. The medium also reflects liver 
function, and a wide range of normal liver function tests have been em­
ployed to monitor liver viability (Ross, 1972; Ritchie and Hardcastle, 
1973). The use of whole blood necessitates the inclusion of long-term 
(storage) and/or short-term anticoagulants such as citric acid and 
heparin. On-line monitoring of hemoglobin, hematocrit and pH must be 
carried out, as well as the aforementioned levels of nutrients and blood 
gases. The choice of donor species of animal must also be considered. 
Larger liver masses have greater metabolizing capacities per unit time and 
require larger perfusate pools for their maintenance. Weights of pig 
livers used in ex vivo perfusion studies have typically averaged 1 kg 
(Eiseman et al., 1965, 1970); Hardison et al., 1967; Mieny and Eiseman, 
1968; Winkler et al., 1971). With such large masses being used, Winkler 
et al. (1971) noted that variable positioning of the liver in its chamber 
will alter the flow of perfusate through it, making it uneven at pressure 
points. Design of the liver chamber must take this into consideration. 
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III. MATERIALS AND METHODS 
Recoveries of parathion, paraoxon and _g-nitrophenol from pig's blood 
and liver were determined first to elucidate tissue extraction efficiency, 
degree of tissue binding and degree of tissue metabolism (for blood only). 
This was followed by isolated, whole pig liver perfusion studies of para­
thion absorption and metabolism in an ^  vivo artificial perfusion system. 
Pigs were used as the model animal for five reasons: (1) The anatomical 
structure and physiological functions of many of their biological systems 
closely resemble those of humans (Howard et al., 1969; Howard and Clarke, 
1970; Lumb and Singletary, 1962; Miller et al., 1962; Millikan et al., 
1974); (2) The size of the liver provides easy manipulation of the organ 
and perfusion system, as well as providing a metabolizing mass great 
enough to enable the use of a conveniently large quantity of input para­
thion; (3) The size of the adult pig's blood pool allows the collection of 
homologous perfusate blood from only one blood donor for each perfusion 
trial; (4) The pig is an accelerated model for human growth, so that body 
functions of the pig up to several months of age are equivalent to those 
of a growing child over several years; (5) Pigs are an important agricul­
tural commodity in an environment where there is intensive use of agricul­
tural insecticides on plant products grown for animal feeds. There is a 
potential for Insecticide exposure for this sensitive species with the 
possibility of carrying residues to humans. 
The nature of this study (uptake, clearance and metabolism of para­
thion) necessitated the use of large enough quantities of parathion to 
supersede blood and perfusion system binding, in order that recoverable 
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parathion and metabolite levels might be obtained. Preliminary studies 
with parathion and paraoxon in blood at levels ranging from 8.5-40.0 ppm 
revealed that binding of parathion and paraoxon to blood and the perfusion 
system hardware would hamper the investigation of hepatic uptake and 
clearance at input concentrations of less than 40 ppm. Therefore, 40 ppm 
was selected as the input concentration for uptake and clearance studies. 
Subsequent perfusion studies supported the use of this level, since (1) an 
input concentration of 33.9 ppm parathion failed to produce an observable 
second pass pulse of parathion through the liver (vide Figure 8, page 62), 
(2) the depletion rate of parathion at the 40 ppm input level fell to a 
point just within the lower limit of parathion detectability in perfusate 
samples collected 60 min post-addition of parathion to the perfusion sys­
tem (vide Figure 10, page 65) and (3) blood paraoxon remained at levels 
just above the lower limit of paraoxon detectability for the analytical 
method used (vide Figure 11, page 67). Although four trials were carried 
out at the 40 ppm level, an additional trial was conducted at the 33.9 ppm 
level (for parathion first pass absorption determination) and at the 52.8 
ppm level (for first pass absorption, clearance and metabolism determina­
tions) . 
Preliminary studies of parathion recovery from saline were conducted 
at levels 25%, 50% and 75% of the 40 ppm input concentration. Preliminary 
studies of paraoxon recovery /Jrom blood were carried out at levels 20%, 
40% and 60% of the 40 ppm parathion input concentration. These levels 
were used to reflect changing parathion and paraoxon concentrations in the 
perfusion system. 
Studies on human occupational exposures to parathion (Simpson and 
Beck, 1965; Wolfe et al., 1967) have revealed that parathion application 
rates of 2-3 lb active ingredient as a spray per acre of treatment plot 
will result in a 47 mg/hr dermal exposure rate to humans in the treatment 
area. The researchers further concluded that prolonged exposure to 68 
mg/kg dermally would be fatal. Under these circumstances, assuming that 
only part of this exposure level would be absorbed into the bloodstream 
and over an extended time period, the pulsatile addition of 40 ppm direct­
ly to the bloodstream, as in this study, would be a lethal dose. 
A. Animal Maintenance and Blood Storage 
Test animals were pigs of Hampshire, Yorkshire/Hampshire, Yorkshire/ 
Chester or Landrace/Yorkshire breeds, 2-4 months of age and averaging 30 
kg weight. Animals were fed on milk to 3 weeks of age, then water and 18% 
protein pig starter, consisting of milk, com, soybean, alfalfa, meat and 
bone meal ^  libitum. The feed was supplemented with carbadox antibiotic 
(40 g/ton), with an average daily intake of 30 mg. Animals were reared at 
the Swine Breeding Farm of Iowa State University, then moved to the Dairy 
Nutrition Farm of Iowa State University 24 hours prior to experimentation. 
Feed and water were continued ^  libitum; animals were fasted 12 hours 
before surgery. 
In all blood recovery and perfusion experiments, blood was drawn from 
Yorkshire, Hampshire, Duroc or Yorkshire/Hampshire/Duroc tricross breeding 
sows at the Swine Breeding Farm by vena cava puncture with a 10 gauge 
needle into sterile 600 ml blood collection bottles (Diamond Laborato-
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ries) containing 75 ml acid-citrate-dextrose anticoagulant (Solution A). 
The blood was stored at 4°C and used within 3 weeks of collection. Blood 
collected for perfusion experiments was used within 48 hours of collec­
tion, and blood from only one animal was used in any one experiment. 
Prior to use, the anticoagulant was converted to heparin by the addition 
of 10,000 units of sodium heparin (Upjohn) per liter of blood, followed by 
400 mg CaClg (Upjohn) (Norman et al., 1966a). 
B. Recoveries of Parathion, Paraoxon and 
p-Nitrophenol from Blood and Liver 
Technical grade parathion (Monsanto) and paraoxon (Chem Service) were 
column purified according to Nakatsugawa et al. (1968). Reagent grade 
2-nitrophenol (Fisher Scientific) was recrystallized from ethanol. Gas 
liquid chromatographic (GLC) analysis of parathion and paraoxon was 
accomplished on a Varian 3700 gas chromatograph using an electron capture 
detector and a 97 cm x 2 mm i.d. glass column packed with 3% apiezon N on 
60/80 mesh, acid washed, dimethyl chlorosilane-treated Chromosorb G 
(Supelco), and further silanized with 25 yl Sily1-8® (Pierce). Carrier 
nitrogen flow was 32 ml/min, and temperature conditions were inlet 220°C, 
oven 180°C and detector 300°C. Standard parathion and paraoxon GLC injec­
tion solutions were prepared from purified compounds in hexane (Nano-
grade , Mallinckrodt). Spectrophotometric analyses of £^-nitrophenol were 
carried out on a Beckman model DB spectrophotometer. All analytical 
glassware which parathion or its metabolites might have contacted was 
siliconized with Siliclad®(Clay-Adams). 
33 
1. Parathion recoveries from saline and blood 
To determine if parathion extraction losses in the perfusion experi­
ments were due to blood binding or metabolism, comparative extraction re­
covery determinations were conducted from physiological saline. 
a. Recovery from saline From a stock solution of parathion 
(48.5 ug/ml) emulsified in physiological saline (0,9%) (Travenol) with 2% 
(§) 
Tween 80 (polyoxyethylene sorbitan monooleate), ^  5 ml volumes were 
placed in 29 x 100 mm glass, screw top centrifuge tubes. All volumes were 
brought to 5 ml with 2% Tween 80 in physiological saline to give final 
concentrations of 9.7, 19.4 or 29.1 ppm parathion. The samples were agi­
tated for 2 min (Vortex, Scientific Industries) and held at 4°C. Samples 
at each concentration were extracted with 20 ml hexane at 0, 12, 18 and 
24 hours after addition to the centrifuge tubes, centrifuged for 5 min at 
1020 ^  on an International centrifuge (model K), and the hexane layer 
decanted into 17 x 60 mm glass vials for GLC analysis to determine para­
thion recovery. Samples were stored at -20°C until analyzed. 
b. Recovery from blood From a stock solution of parathion (2 
mg/ml) emulsified in saline as in the saline extraction trial, 2 ml were 
placed in a 250 ml Erlenmeyer flask containing 98 ml blood at 37°C in a 
controlled environment incubator shaker (New Brunswick, model G25) to give 
a blood parathion concentration of 40 ppm. During 60 min of shaking and 
incubation at 37°C, 13 x 5 ml aliquots drawn at intervals were placed in 
16 X 125 mm glass, screw top centrifuge tubes and held at 4®C for 18 
hours. This was to be the storage time for perfusate samples prior to 
extraction. The samples were extracted and analyzed as in the saline 
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extraction trial. This procedure was repeated with incubation and stir­
ring at 4°C to inhibit enzymatic metabolism in the blood. 
2. Paraoxon recovery from blood 
From a stock solution of paraoxon (255 yg/ml) emulsified in saline as 
in the saline extraction trial, ^  1 ml aliquots of accurately known 
quantities were placed in 29 x 100 mm glass, screw top centrifuged tubes. 
All volumes were brought to 1 ml with 2% Tween 80 in physiological saline, 
and 5 ml whole blood were added to each tube to give final blood paraoxon 
concentrations of 8.5, 17.0 or 25.5 ppm. The samples were stored, ex­
tracted at 0, 12, 18 and 24 hours, centrifuged and analyzed according to 
the method described for the parathion recovery determination from saline. 
3. Extraction of p-nitrophenol from blood 
From a stock solution of £-nitrophenol in ethanol (0.25 mg/ml), 5 ml 
were added to 120 ml whole blood in a 250 ml Erlenmeyer flask to give a 
final blood concentration of 10 ppm. The mixture was stirred for 30 min 
at 25°C, and then ^  5 ml aliquots of accurately known quantities were 
placed in 29 x 100 mm glass, screw top centrifuge tubes. All volumes were 
brought up to 5 ml with unspiked whole blood to give final tube concentra­
tions ranging from 1.02-9.20 ppm. The tubes were left for 30 min at 25°C, 
1 ml 12% trichloroacetic acid added to each and then agitated for 2 min. 
The samples were then extracted with 20 ml hexane, followed by 10 ml 
chloroform:ether (5:1 v/v) and centrifugation at 650 ^  for 5 min. After 
transferring 5 ml of the chloroform ether layer to a glass, screw top, 
16 X 125 mm culture tube, 3 ml 0.05 M Na^CO^ in 24% ethanol were added, 
and the ^ -nitrophenol extracted into the aqueous phase with shaking for 2 
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min. The transfer of ^ -nitrophenol from the organic to aqueous layer was 
noted by the appearance of a yellow color in the aqueous layer. The cul­
ture tubes were centrifuged at 1020 ^  for 15 min and the aqueous phase 
containing the p-nitrophenol analyzed spectrophotometrically at 400 nm. 
The chloroform:ether layer was analyzed for £-nitrophenol by thin layer 
chromatography on 0.25 mm thick silica gel F 254 plates (Brinkmann), de­
veloped with hexane:ethyl acetate (2:1, v/v) and visualized under fluores­
cent light. 
4. Recovery of parathion, paraoxon and p-nitrophenol from liver 
Each of 3 x 5 g samples of freshly removed porcine liver was placed 
in a 29 X 100 mm glass, screw top centrifuge tube, held at 4°C. To each 
tissue sample was added 1 ml parathion (200 yg/ml) emulsified in physio­
logical saline with 2% Tween 80 to give a liver parathion concentration of 
40 ppm. The samples were held at 37°C for 60 min, quick frozen at -86®C 
in a dry ice/acetone mixture and then held at -20°C for 96 hours. The 5 g 
samples were then homogenized with 10 ml 0.25 M sucrose in a Servall 
omni-mixer for 5 min, transferred to a Teflon pestle homogenizer attached 
to a high speed drill, and with an additional 15 ml sucrose homogenized 
for another 2 min. Two 10 ml aliquots were each transferred to a 29 x 
100 mm glass, screw top centrifuge tube and the contents of each tube ex­
tracted for 2 min with 10 ml hexane. After centrifuging at 650 ^  for 5 
min, hexane aliquots of 5 ml from each tube were combined and analyzed for 
parathion by GLC as described on page 32. This procedure was repeated for 
(1) paraoxon (200 yg/ml) emulsified in physiological saline with 2% Tween 
80 and (2) p-nitrophenol (200 yg/ml) in ethanol. 
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The £-nitrophenol recovery determination was continued on the hexane 
extracted samples by removing all of the hexane, adding 5 ml 12% tri­
chloroacetic acid to each tube, repeating the hexane extraction with an 
additional 10 ml, followed by recentrifugation. After removing the second 
hexane layer, the ^ -nitrophenol in each of the two tubes was extracted for 
2 min with 7 ml chloroform; ether (5:1, v/v), followed by centrifugation 
at 650 ^  for 5 min. Extraction and analysis of jg;-nitrophenol was com­
pleted following the procedure used for £-nitrophenol extraction from 
blood, except that 5 ml aliquots of the chloroform:ether layer from the 
two centrifuged extracts were combined and subsequently extracted with 
6 ml 0.05 M Na^COg solution in 24% ethanol. A standard calibration graph 
was prepared from known quantities of p-nitrophenol in 0.05 M NagCO^ in 
24% ethanol. The chloroform;ether layers of all liver extractions were 
tested for £-nitrophenol presence by thin layer chromatography. 
C. Perfusion Studies with Parathion 
Eight separate perfusions were carried out, consisting of two blank 
runs without a liver, three trials of parathion absorption by the liver on 
first and second passes and four trials of parathion metabolism by the 
perfused liver over 60 min. One trial was a combined first and second 
pass absorption/60 min metabolism study. Each liver trial entailed liver 
removal, priming of the perfusion system, perfusion maintenance, monitor­
ing normal liver function and conducting parathion tests. 
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1. Liver removal 
The procedure used is a modification of those used by Eiseman et al. 
(1961), Norman et al. (1966b) and Tauber et al. (1971). The animal was 
weighed, anesthetized with halothane (Fluothane , Ayerst) and placed in a 
® 
supine position. After scrubbing with green soap and Zephiran tinctures, 
@ 
the abdomen was covered with surgical film (Vi-DRAPE , Aeroplast), fol­
lowed by laparotomy and exposure of the abdominal viscera with self-
retaining tissue retractors. The bile duct was isolated and cannulated 
ca. 3.8 cm distal to the cystic bifurcation, using 3 mm i.d. vinyl tubing 
with a 1.27 cm long bevel at the tip. The bevel was completely contained 
within the bile duct with the cut edge of the bevel facing the liver, so 
that the beveled portion thus served as a support for the bile duct. This 
prevented occlusion of the duct by its collapse under the weight of the 
liver once in the perfusion chamber. The cystic duct was then ligated to 
prevent the outflow of gall bladder bile. The sclerotic connective tissue 
binding the liver to the peritoneum was severed, the portal vein isolated 
from the hepatic lymph nodes and surrounding connective tissue, and the 
posterior vena cava isolated at its entrance and exit from the liver.^ 
The animal was then heparinized (100 units/kg body weight), respiratory 
assist initiated (demand assist; respiratory rate = 15 cycles/min) and the 
thorax exposed by xiphisternal incision. The vena cava anterior and 
^Early surgical preparations included isolation of the hepatic artery 
prior to this step, followed by later ligation proximal to the gastro-
duodenal artery. It was subsequently determined that complete constric­
tion and occlusion of the artery was effected physiologically by endoge­
nous catecholamines, dispensing with the need for ligation. 
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posterior to the diaphragm was then isolated from the diaphragm, leaving a 
cuff of the diaphragm around the vessel. Complete removal of the liver 
was effected by (1) clamping the anterior vena cava with a straight hemo-
stat and severing distally,^ (2) clamping the posterior vena cava caudal 
to the liver and severing distally and (3) clamping the portal vein just 
proximal to the anastomosis of the superior mesenteric, inferior mesen­
teric and splenic veins, and severing distal to the clamp. The liver was 
inverted within the abdominal cavity and the portal cannula (silicone 
tubing, 0.95 cm i.d., 35 cm long with cuff to prevent slippage of the 
suture tie to the portal vein) inserted and secured to the portal vein 
with suture thread. Flushing of the liver was begun via the portal can­
nula with 500 ml heparinized (10 units/ml) lactated Ringer solution 
(Travenol) at 39*C from a height of 90 cm. While flushing proceeded, the 
caval cannula was tied into the prehepatic posterior vena cava, leaving 
the anterior vena cava clamped with a hemostat. The portal cannula was 
clamped just before the entire volume of the lactated Ringer solution 
drained into the liver to avoid air locks and vascular emboli in the 
liver, and the cannulated liver transferred to the liver perfusion chamber 
seated on scales. The liver was weighed, and the portal and caval cannu-
lae linked to the chamber connectors (vide Figure 4). The chamber was 
closed, placed on its support stand and hooked into the primed perfusion 
system. 
^The posthepatic posterior vena cava is very short; due to late 
emerging hepatic veins, it was necessary to clamp the anterior vena cava 
to preclude leakage by these late emerging vessels during perfusion. 
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2. Perfusion system 
The perfusion unit was a recirculating system consisting of a blood 
reservoir (600 ml capacity), roller pump (Sams, #3500), disposable mem­
brane oxygenator (Travenol, #0321), disposable heat exchanger (Travenol, 
#0337), extracorporeal flow probe (Biotronix, #BL C-2096), 39°C water bath 
(Blue M, #MSB-3222) with water circulator (Haake, #E12) for the heat ex­
changer, oxygenator and heat exchanger connectors (Travenol, #5422), three 
perfusate sampling ports (Travenol, #6512) with stopcocks (USCI, #003987), 
liver chamber connectors (Travenol, #6502) and liver in its chamber (vide 
Figure 4). All apparatus was connected with 0.95 cm i.d. Silastic tubing 
(Dow Coming, #601-525), with lengths specified in Figure 4. All surfaces 
of the system exposed to blood, liver or bile were made of glass (blood 
reservoir, bile reservoir and liver chamber). Teflon (liver support and 
stopcocks), stainless steel (flow probe, oxygenator connectors, heat ex­
changer connectors, chamber connectors, sampling ports and the heat ex­
changer) , silicone rubber (blood cannulae, circuit tubing, oxygenator gas 
exchange membrane, oxygenator and heat exchanger linings) or polyvinyl 
chloride (bile cannula). All glass and stainless steel parts were silico­
nized with Siliclad (Clay-Adams) except the flow probe and heat exchanger. 
The glass liver chamber and support are illustrated in Figure 4. Ascites 
fluid from the liver was retumed to the system via the blood reservoir. 
Ancillary equipment used consisted of siliconized organ and perfusate 
thermistor probes (Yellow Springs, #416 and #403) hooked up to tele-
thermometer units (Yellow Springs, #43TD) and a flowmeter (Biotronix, 
#BL-610-2A), hooked up to the flow probe. The circuit apparatus was 
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mounted on a Plexiglas circuit board or positioned on a cart to which the 
circuit board in turn was mounted. 
The assembled system was primed with homologous whole pig's blood, 
collected from breeding sows within 48 hours of use and stored at 4°C in 
ACD anticoagulant. At the time of animal anesthesia induction, the blood 
was heparinized, recalcified (vide page 32) and filtered through a blood 
administration set (Diamond Laboratories, #5000798) into a graduated 
cylinder for accurate volume measurement. The perfusate was then trans­
ferred to the blood reservoir and the closed system, minus the liver 
chamber, primed with an accurately known quantity of approximately 1.5 
liters of blood. The pump was activated at a low flow rate and the system 
was primed independently during liver retrieval, voiding air bubbles, 
maintaining the temperature at 39°C and oxygenating the perfusate to 
saturation with oxygen and carbon dioxide (95:5). 
The liver in its chamber was incorporated into the primed system by 
(1) stopping the pump, (2) pinch clamping the perfusion line on either 
side of the hepatic venous sampling port, (3) separating the line at the 
sampling port and (4) connecting the portal and hepatic venous lines to 
the chamber connectors to meet the liver cannulae. The pinch clamps on 
the perfusion line were then removed, the air locks in the cannulae voided 
through the portal and hepatic venous sampling ports with syringe suction, 
the portal cannula clamp removed and the pump started. The total ischemic 
period for the liver was ca. 15 min. 
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3. Perfusion maintenance conditions 
The perfusate temperature was maintained at 39°C. As indicated by a 
thermistor probe placed between the quadrate and left lobes of the liver, 
organ temperature increased from 35®C to 38°C within 30 min of perfusion. 
Liver system equilibration was allowed to proceed for 60 min after hookup, 
the first 30 min of which the perfusate flow rate was increased from 100 
ml/min to 700 ml/min/kg liver. This was based on an optimal total hepatic 
flow rate of 1 liter/min/kg liver, 60-70% of which is portal flow 
(Winkler et al., 1971). During the equilibration period, the pH of the 
perfusate was monitored and adjusted to 7.35-7.45 with 100-200 ml of a 
7.5% solution (0.892 mEq/ml) sodium bicarbonate (Vitarine). The hemato­
crit was reduced to 30% with lactated Ringer solution and the hemoglobin 
content of the perfusate measured with a hemoglobinometer (American 
Optical, #1000). When the perfusate flow rate was at its optimal level, 
blood pressures were taken at the oxygenator, portal and hepatic venous 
sampling ports with the aid of a Hewlett Packard/Sanborn transducer 
(#267BC), carrier amplifier system (#350-11000 and recording unit (7700 
series). 
4. Normal liver function parameters 
After the 60 min equilibration period, perfusate lactate and pyruvate 
were determined from a 3 ml venous sample drawn directly into 6 ml 8% 
perchloric acid at 4°C from the hepatic venous sampling port. Lactate and 
pyruvate were quantitated with chemicals from and according to the proce­
dure of the Sigma Chemical Company (Technical Bulletin number 726-UV). 
Pyruvate analysis involved spectrophotometric measurement of NAD produced 
from NADH in the conversion of pyruvate to lactate. Lactate measurement 
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involved the reverse reaction. Analyses of 3 replicate supernatant sub-
samples were carried out on a Beckman model DB spectrophotometer, using 
calibration graphs prepared from known quantities of pyruvate and lactate. 
Perfusate ATP was determined from a 2 ml hepatic venous sample drawn 
directly into 4 ml 12% trichloroacetic acid at 4°C from the hepatic venous 
sampling port. Analysis was carried out with chemicals and procedure of 
the Sigma Chemical Company (Technical Bulletin number 366-UV), and 
quantitated spectrophotometrically with the aid of a standard calibration 
solution of ATP. The method involved reacting ATP with 3-phosphoglyceric 
acid to produce 1,3-diphosphoglyceric acid. This was then reacted with 
added NADH to produce NAD, which was measured spectrophotometrically. 
Three replicate subsamples from the supernatant were used. The lactate, 
pyruvate and ATP quantitations were repeated 180 min after liver hookup. 
Bile was continually collected from the bile duct cannula and the 
bile flow rate recorded throughout the perfusion. 
5. Parathion tests 
All blood and liver parathion and paraoxon analyses were carried out 
as conducted in the extraction recovery determinations (vide pages 32-34). 
Analyses for p;-nitrophenol were performed on the parathion/paraoxon ex­
tracted blood and liver samples, beginning with removal of residual ex­
tracting hexane and addition of 12% trichloroacetic acid. Combustion 
14 14 
analyses for C from C-ethyl parathion in blood, liver and bile were 
performed on a biological oxidizer (R. J. Harvey, model BM)), using 
14 purified C-aldicarb for standardization and efficiency of counting de-
14 
terminations. C contents of the combusted samples were quantitated in 
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a trapping/counting cocktail (R. J. Harvey) using a Packard Tri-Carb 
liquid scintillation counter (#3003). ^^Cr used as a vascular reference 
substance in red blood cells was quantitated on a Nuclear Chicago gamma 
counter (#8725). 
a. Blank perfusion Two perfusions were run replacing the liver 
with 12.5 meters of 0.95 cm i.d. silicone tubing to accommodate the 
equivalent blood perfusate volume used in liver perfusions (vide Table 1, 
pages 53-54). The blank runs were conducted to determine (1) the ^^Cr-
labeled red cell and parathion profiles at the hepatic venous sampling 
port without the influence of the liver and (2) the degree of parathion 
binding to components of the perfusion system. As in liver runs, optimal 
perfusate temperature and oxygenation were maintained. 
The first blank run was conducted to determine ^ ^Cr-labeled red blood 
cell (^^Ci?-rbc) and parathion outflow profiles within the first 290 sec 
post-addition to the system. ^ ^Cr-rbc's were prepared according to the 
methods of Sterling and Gray (1950) and Gray and Sterling (1950). Whole 
blood (10 ml) was incubated with 0.973 mCi (0.76 mCi/ml) Nag^^CrO^ in 
sterile physiological saline (Amersham) at 25°C. The red cells were then 
washed three times with physiological saline and packed to give a specific 
activity of 19.26 yCi/ml. Parathion (5.7 ml of 19.07 mg/ml in physiologi­
cal saline emulsified with 2% Tween 80) was combined with 2.3 ml packed 
^^Cr-rbc's to give a test mixture of parathion (13.58 mg/ml) and ^^Cr-
rbc's (56.6 yCi/ml). ^^Cr specific activity was confirmed by gamma count­
ing and the parathion concentration confirmed by GLC. Then 5 ml of the 
test mixture were added to the total perfusate volume (1667 ml) via the 
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reservoir to give distributed perfusate concentration of 40.7 ppm para-
thion and 0.17 yCi/ml ^^Cr. Fifteen seconds after addition of the mixture 
to the reservoir, 60 x 1.4 ml samples were drawn from the venous sampling 
port continuously with the aid of a rapid blood sample collector (Rothe 
and Sapirstein, 1954; McGilliard et al., 1971), modified to turn at a rate 
of 1/2 rpm. At the end of one complete cycle of the sampler, each sample 
represented a 2 sec collection time. Continuous sampling proceeded for 2 
min followed by drawing of 7 x 8 ml samples at 20 sec intervals into 
Vacutainer tubes (Beeton-Dickinson, #4710), until 290 sec post-addition 
of the parathion/^^Cr-rbc mixture to the system. 
Exactly 0.1 ml whole blood was transferred from each of the 60 con­
tinuous samples plus the 7 subsequent samples into 6 inch test tubes for 
^^Cr activity determination by gamma counting (counting efficiency = 
2.37%). The 60 continuous samples were then pooled sequentially into 12 
groups, each containing 5x2 sec samples. These 12 pooled samples plus 
the 7 Vacutainer samples, as well as pretest blood samples drawn for blank 
value determinations, were subjected to parathion, paraoxon and £;-nitro-
phenol analyses as indicated on page 43, 18 hours after sampling and 
holding at 4°C. 
The objective of the second blank run was to determine the degree of 
parathion binding to the blood perfusate and the perfusion system's hard­
ware over a range of concentrations (10, 20, 30 and 40 ppm) and an ex­
tended time period (240 min in total). Using the same conditions as in 
the previous blank run, parathion emulsified in physiological saline with 
Tween 80 was added to a total perfusate volume of 1845 ml to give a 
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distributed parathion concentration of 10 ppm. During the next hour, 9 x 
5 ml perfusate samples were drawn from the venous sampling port into 
Vacutainer tubes (Becton-Dickinson, #4768). The 45 ml removed from the 
system by sampling were replaced with 45 ml bank blood, the parathion 
concentration in the system raised to 20 ppm and sampling carried out 
again as before. The entire procedure was continued at parathion concen­
trations of 30 ppm and 40 ppm. Pretest perfusate samples were drawn prior 
to parathion addition. All samples were analyzed for parathion, paraoxon 
and 2"]^it]^ophenol according to the procédures indicated on page 43. 
b. Absorption of parathion by the liver during first and second 
passages As presented in Table 1, pages 53-54, the procedure identical 
to the first blank run with parathion and ^^Cr-labeled red blood cells was 
repeated three times with the liver in place, using an input parathion 
concentration of 33.9, 41.0, or 52.8 ppm, and an input ^^Cr activity of 
0.48-0.49 yCi/ml perfusate. In one instance Vacutainer sampling was 
stopped at 250 sec. In the second instance sampling was continued for 30 
min, and in the third instance sampling was extended for 60 min post-
addition of the parathion/^^Cr-rbc mixture to the system. 
c. Parathion metabolism by the perfused liver Four separate 
perfusions were conducted to determine the metabolic fate of parathion in 
the perfusion system. Initial parathion input concentrations were 40.2, 
41.2, 40.4 and 52.8 ppm, as indicated in Table 1, pages 53-54. In all 
four runs, over one hour post-addition of parathion to the system 13 x 5 
ml perfusate samples were drawn from the hepatic venous sampling port into 
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Vacutainer tubes, stored and analyzed in a manner identical to samples 
taken during all previous runs. The metabolism study at the 52.8 ppm 
level also incorporated a first and second pass parathion absorption test; 
this was the 60 min trial referred to in the previous section. 
Combustion analyses were conducted on blood, liver and bile samples 
of the 40.4, 41.2 and 52.8 ppm trials. This was facilitated by the use of 
(ethyl-l-^^C)-parathion (Amersham), added to the parathion emulsion prior 
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to preparation of the parathion/ Cr-rbc mixture. The C-parathion spe­
cific activities in the perfusates of the three trials ranged from 0.003-
0.008 yCi/ml perfusate. For blood combustion analysis, 0.5 ml from each 
of the Vacutainer samples was transferred to a separate tube at sampling 
time, the plasma allowed to separate overnight at 4''C and the samples 
frozen at -20°C for five days until combustion analysis. Aliquots of 
plasma and red cells (100 yl each) from test and pretest perfusate samples 
were combusted and the radioactivity quantitated as indicated on pages 43-44. 
Bile collected prior to parathion addition and during testing was com­
busted in 100 Til quantities. At the end of each liver perfusion, liver 
samples from the proximal, central and distal regions of each of the three 
primary lobes (left, right and quadrate) were quick frozen at -86®C in dry 
ice/acetone and then held at -20°C for five days. Combustion analysis on 
blotted, 400-600 mg liver samples from each section of each lobe was then 
carried out. 
Liver microsomal protein analysis was conducted on quick frozen sam­
ples taken during the four metabolic studies. Microsomes were isolated 
according to the method of Falade and Siekevitz (1956) with the aid of a 
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Beckman ultracentrifuge (model L2-65), and analyses performed according to 
the method of Lowry et al. (1951). All liver and blood chloroform:ether 
extracts in the analysis for ^ -nitrophenol were subjected to thin layer 
chromatography to confirm the absence of £-nitrophenol, according to the 
procedure described on page 35. 
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IV. RESULTS 
A. Recoveries of Parathion, Paraoxon and 
2-Nitrophenol from Blood and Liver 
Parathion recoveries from physiological saline and blood are pre­
sented in Figure 5. At initial concentrations of 9.7, 19.4 and 29.1 ppm 
in saline, recoveries after 18 hours of sample storage at 4®C were 84.0%, 
95.0% and 103.3% of the initial quantity (Figure 5A). No paraoxon was 
recovered from any samples. The recovery profiles indicate that at con­
centrations lower than 20 ppm, the degradative or binding actions of iso­
tonic saline reduce the amount of recoverable parathion. Recoveries of 
parathion over 60 min from blood incubated at 4°C and held for 18 hours 
ranged from 67.8% to 69.2% (X = 68.5%) of an initial concentration of 
41.2 ppm. Recoveries of parathion from blood incubated at 37°C and subse­
quently held for 18 hours at 4°C ranged from 64.8% to 66.4% (X = 65.6%) 
(Figure 5B). 
Paraoxon recoveries from blood (Figure 5C) containing 8.5, 17.0 and 
25.5 ppm paraoxon were 78.0% at the 8.5 ppm level and 52.0% for both the 
17.0 and 25.5 ppm levels, 18 hours after storage at 4°C. The two higher 
paraoxon concentrations followed a similar recovery pattern. The in­
creased recovery from a lower blood concentration suggests that extraction 
efficiency, not blood binding and/or metabolism, is responsible for this 
trend, since binding or metabolism would not cause percent extractable 
paraoxon to decrease with increasing concentration. 
Figure 5. Extraction recoveries of parathion from physiological 
saline and blood, and paraoxon from blood (0, 12, 18 and 
24 hours after storage at 4°C) 
A. Recoveries of three parathion concentrations from 
saline 
B. Recoveries of parathion from blood at a concentration 
of 41.2 ppm, after 0-60 min of incubation at 4°C or 
37°C, followed by 18 hours of storage 
C. Recoveries of three paraoxon concentrations from blood 
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Extraction of 1.02-9.20 ppm p^nitrophenol in blood produced a linear­
ly increasing spectrophotometric absorbance at 400 nm (slope = 0.011, r = 
0.997). With a thin layer chromatographic limit of detectability of 5 yg 
p-nitrophenol by ultraviolet fluorescence, no £-nitrophenol was detectable 
in the chloroform:ether intermediate extracts. 
Parathion, paraoxon and ^ -nitrophenol recoveries from spiked liver 
samples were 95.2%, 93.5% and 99.0% respectively. 
B. Perfusion Studies with Parathion 
Parameters relating to test animals, perfusion maintenance conditions 
and normal liver function tests conducted during perfusion are presented 
in Table 1 for all six liver perfusions. Induction of anesthesia prior to 
liver retrieval for liver perfusion was rapid (<60 sec) and surgical anes­
thesia was achieved within 10 min of induction. Minor variations in 
anatomical relations, sizes of blood vessels and sizes of ducts were ob­
served. Bile flow was present after cannulation of the bile duct and 
continued throughout surgery after cystic ligation. Liver color remained 
pink to red until isolation; flushing with lactated Ringer solution prior 
to placement in the chamber caused the liver to turn white. All subse­
quent perfusion maintenance and normal liver function values obtained are 
comparable with those reported by others (vide Table 1). 
1. Recovery of parathion in blank perfusion 
Incremental addition of parathion over 4 hours to result in concen­
trations of 10, 20, 30 and 40 ppm in a perfusion preparation without a 
liver produced the effect shown in Figure 6. The blood volume, pH and 
Table 1. Experimental conditions of liver perfusion studies with para-
thion (test studies included first and second pass absorption 
of parathion by the liver, and 60 minute metabolic studies; 
literature values and references are cited for comparison; blank 
spaces appear where values do not apply to the experiment being 
conducted) 
First and second 
pass studies^ 
Trial number 1 2 
Pig weight (kg) 29.5 27.2 
Liver weight at removal (kg) 1.00 1.04 
Liver weight gain to end of perfusion (kg) 0.37 0.44 
Blood perfusate values at or during test time: 
Volume (1) 1.850 2.239 
pH 7.34 7.46 
Hematocrit 0.31 0.32 
Hemoglobin 8.40 10.10 
Blood pressure (mm Hg) at: 
Portal sampling port 15.3 16.0 
Hepatic venous sampling port -1.7 -3.0 
ATP (ymoles %)d 102.0 39.9 
Lactic acid (mM)^ 14.7 17.8 
Pyruvic acid (mM)*^ 0.41 0.31 
Lactate/pyruvate^ 35.9 57.4 
Bile flow during perfusion (yl/min/kg liver) e 122.3 
Liver microsomal protein (mg/g liver) 
Initial parathion concentration 
in perfusate (ppm) 41.0 33.9 
Included in the first and second pass studies is also trial number 6. 
^Liver weight loss. 
^ased on a hematocrit of 0.46. 
"S^alues are averages of 2 perfusate samples taken before (60 ni-tn of 
perfusion) and after (180 min of perfusion) parathion tests. 
^alue not taken. 
54 
Literature values 
60 minute metabolic studies and references 
3 4 5 6 
28.2 30.9 39.0 28.6 
0.72 1.20 1.31 0.94 
0.02 0.34 -0.15b 0.28 
1.396 1.483 1.426 1.714 
7.35 7.43 7.51 7.52 7.45 Tait and Eiseman, 1966 
Weber et al., 1973 
Wilhelm et al., 1977 
0.24 0.26 0.25 0.20 C .25-0.30 Tauber et al., 1971 
7.40 7.70 8.50 7.95 15.3= Tegeris et al., 1966 
13.5 12.0 14.7 9.0 12-14 Norman et al., 1966c 
-2.1 1.8 -4.0 -2.8 -5-0 Eiseman, 1966 
104.1 111.6 83.1 47.5 
11.3 12.0 15.1 17.0 17 Sestoft et al., 1972 
0.32 0.35 0.35 0.38 0.3-0.7 Sestoft et al., 1972 
35.3 34.3 43.1 47.1 20-24 Abouna et al., 1969 
19.9-58.2 Narvanen, 1966 
30-80 Sestoft et al., 1972 
6-27 Tygstrup et al., 1971 
107.8 105.8 97.5 93.0 Abouna, 1968 
83-303 Sestoft et al., 1972 
Tait and Eiseman, 1966 
Tygstrup et al., 1971 
119 Winkler et al., 1971 
1.6 4.5 15.3-20.4 Andreasen et al., 1977 
12.2-21.6 Freudenthal et al., 1976 
40.2 41.2 40.4 52.8 
Figure 6. Recovery of parathion from a perfusion preparation with the 
liver substituted by silicone tubing (10 ppm injections 
were made four times at 60 minute intervals) 
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hematocrit for the trial were 1.850 1, 7.50 and 0.31, respectively. 
These values are in good agreement with those in Table 1. Each addition 
of 10 ppŒ. at 60 min intervals was succeeded by a steady removal of re­
coverable parathion from the blood perfusate to approximately the same 
level 40 min post-addition. This was followed by a leveling off until the 
next 10 ppm incremental addition (Figure 6B). The overall result was a 
constant removal of recoverable parathion over the 10-40 ppm range (dotted 
line in Figure 6A). These data indicate a slow steady binding with time, 
which continues despite recharges with doubling quantities of parathion to 
the system. With each addition, the equilibrium point drops slightly, 
producing a scalloped negative tilt to the slope. The blood binding 
mechanism approaches equilibrium with each 10 ppm addition. A slow rate 
of blood metabolism, as suggested by Appleton and Nakatsugawa (1977), 
would result in a gradually decreasing parathion pool, as manifested by 
the dotted line in Figure 6A. Binding to components of the perfusion 
system, blood binding and blood metabolism reduced the recovery of para­
thion from 40.6% for the 10 min sample to 17.6% for the 60 min sample. 
Since the preliminary parathion binding study (vide Figure 5B, page 51) 
indicated a 64.8% extraction recovery at 60 min post-addition, the degree 
of system binding reducing this value to 17.6% amounted to 47.2%. The 
pattern of increasing system binding of parathion to 47.2% at 60 min, 
blood binding and blood metabolism was reproducible for all concentrations 
in the 10-40 ppm range. 
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2. First pass and second pass liver absorption of parathlon 
Absorption of parathion during its first and second passes through 
the liver was accomplished by determining the difference in areas under 
the parathion outflow profiles of one blank perfusion and three liver 
perfusions. The initial parathion concentration, blood volume, pH and 
hematocrit for the blank trial were 40.7 ppm, 1.672 1, 7.35 and 0.30, 
respectively. These values are in agreement with those in Table 1. 
Typical outflow profiles for the blank run and a liver run with concomi­
tantly injected ^^Cr-labeled red blood cell vascular markers are presented 
in Figure 7. The first pass outflow curves for 40.7 ppm parathion and 
^^Cr in the blank run (Figure 7A) are similar. 
Parathion first and second passes occurred 50-110 and 110-190 sec 
post-injection into the system. By contrast, parathion first pass outflow 
curves for the three liver trials (41.0, 33.9 and 52.8 ppm) lagged behind 
the ^^Cr outflow profiles. This is a consequence of flow-limited distri­
bution of parathion into the extravascular space and hepatocytes prior to 
its appearance at the venous end as returning material and throughput 
(vide Figure 2, page 20). Initiation of both the parathion and ^^Cr 
pulses occurred more quickly in the liver trials due to the manifolding 
effect of the liver (vide page 15). Manifolding, parathion flow-limited 
distribution and return to the sinusoids caused the parathion outflow 
profiles of the liver trials to be less definitive than those of the blank 
trial. 
The percent parathion recovered at the venous sampling port was 
greatly reduced in the presence of the liver compared to the blank trial 
Figure 7. Hepatic venous outflow profiles of parathion and Cr-
labeled red blood cells added concomitantly to the perfu­
sion reservoir 
A. Blank trial outflow profiles with the liver replaced by 
12.5 m of 0.95 cm i.d. silicone tubing 
B. Outflow profiles with the liver in place 
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output. The difference in areas under the parathion outflow profiles of 
blank and liver runs amounted to the percent parathion taken up by the 
liver. As depicted in Figure 8, for the three parathion test concentra­
tions of 33.9, 41.0 and 52.8 ppm, liver uptakes during first pass were 
97,8, 84.5 and 68.7% of the initial input quantities. The observed trend 
toward a decreasing first pass absorption with increasing initial concen­
tration may have resulted from a more closely approaching saturation of 
the uptake process with increasing concentration. Second pass outflow 
profiles appeared for the trials utilizing the two higher input concentra­
tions. Area differences from the blank run produced second pass absorp­
tion values of 81.7 and 73.0% for the 41.0 and 52.8 ppm levels respec­
tively. 
Predicted second and third pass values presented in Figure 8 are 
extrapolations of actual first pass data, obtained by calculating the 
cumulative amount of input parathion absorbed by the liver during first 
and second passes (first, second and third passes at the 33.9 ppm level) 
as if the percent absorbed during all passes were the same as that of the 
experimentally determined first pass. The deflection of the actual value 
from the predicted value obtained for the second pass (vide Figure 8) 
indicates that liver absorption of parathion declined during passes subse­
quent to the first. This deflection amounted to 15.9% for the 41.0 ppm 
level and 17.2% for the 52.8 ppm level. An actual second pass at the 33.9 
ppm level was not obtained. Predicted third pass values for all three 
concentration levels approach 100%, although the trend indicated by the 
actual values of the second pass suggests that cumulative uptake of para-
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Figure 8. Uptake of parathion by the liver in two successive passes 
(actual values are experimentally determined absorption per-
cents; predicted values are calculated extensions of first pass 
absorption percents) 
63 
thion by the liver would be considerably less than 100% for several 
passes. Furthermore, the observed increasing deviation of cumulative up­
take from the predicted value with increasing input concentration supports 
the notion that as the input concentration increases, the longer the time 
required to achieve 100% uptake by the liver. 
3. Parathion metabolism by the liver 
Four 60-minute metabolic studies were conducted with parathion at 
input concentrations of 40.2, 40.4, 41.2 or 52.8 ppm. The last three 
trials incorporated (ethyl-l-^^C)-parathion. The distribution into 
plasma and red blood cells, presented in Figure 9, rose rapidly and 
14 leveled off at 30% and 8% of the administered C respectively for the 
duration of the experiment. Bile contained less than or equal to 0.6% of 
the administered at all times in all trials, and liver amounted 
to 18.9±2.9%. Combustion analysis of the three primary liver lobes, as 
well as proximal, central and distal portions of each lobe revealed a 
14 
uniform distribution of C among the three lobes and among all sections 
of all lobes. 
Parathion profiles for samples drawn from 3-60 min of perfusion are 
presented in Figure 10. The disappearance curves are characterized by a 
distribution throughout the entire perfusate during the first 10 min post-
addition, followed by a gradual decrease in recoverable parathion over the 
subsequent 30 min. Recovery percentages did not correspond in size with 
increasing parathion input concentrations, although the highest parathion 
input concentration (52.8 ppm) produced a disappearance curve noticeably 
elevated from the three lower concentrations. The 52.8 ppm trial also 
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Figure 9. Distribution of C among blood components after addition of 
(ethyl-l-^^C)-parathion to liver perfusion preparations (data 
are averages of three trials; whole blood values are composites 
of the plasma and red cell values) 
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Figure 10. Parathion recovery in recirculating blood perfusate of liver 
perfusions receiving parathion 
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exceeded the percent parathion in the perfusate indicated by the second 
pass study (vide Figure 8, page 62), and the arcing nature of this curve 
during the 3-10 min sampling period suggests that it was not yet uniformly 
distributed in the perfusate during that time period. The gradual de­
crease in recoverable parathion from 10-60 min post-addition occurred 
after liver uptake saturation within the first 3-4 min suggested in 
Figure 8. This indicates that other factors in addition to hepatic uptake 
and metabolism are in part responsible for parathion's disappearance from 
10-60 min. Blood binding and system binding influences suggested in 
Figure 5B (page 51) and Figure 6 (page 56) may play a role in this 
phenomenon. 
Paraoxon recoveries were obtained in trials at the 40.4 and 52.8 ppm 
levels. As depicted in Figure 11, paraoxon levels in the perfusate ranged 
from 17.0% at 10 min post-addition to 2.5% at 60 min. In both trials, the 
perfusate titer of paraoxon was steady between 15-60 min. Consistent with 
the parathion profiles of Figure 10, the paraoxon curve for the 52.8 ppm 
level is higher than that for the 40.4 ppm level from 15-60 min post-
addition of parathion. 
No 2r]iitrophenol was detected in aqueous or organic extracts of 
perfusate blood from all four trials. 
The average liver contents of parathion, paraoxon and 2rnitrophenol 
for the four trials 60 min after parathion addition were 3.26%, 3.22% and 
14 0% respectively. Figure 12 depicts the distribution of C and added 
parathion in all components of the perfusion system. Total accounta­
bility at 60 min post-addition was 106.6% of the administered quantity. 
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Figure 11. Paraoxon recovery in recirculating blood perfusate of liver 
perfusions receiving 40.4 ppm or 52.8 ppm parathion 
Figure 12. Accountability of C, parathion and paraoxon in blood, 
liver and bile, and as a result of perfusion system 
binding and extraction efficiency (60 minutes after 
addition of (ethyl-l-^^C)-parathion to the perfusion 
preparation) 
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Total parathlon accountability was 93.8% of the administered dose (in­
cluding a parathlon extraction recovery loss of 35.2% according to Figure 
5B, page 51). The high liver content relative to the levels of liver 
parathlon, paraoxon and 2;-nitrophenol suggests that bound and/or conjugat­
ed parathlon and its products, plus liver 0-deethylation of parathlon to 
leave behind the ^^C-ethyl moiety, constituted the unextractable in 
the liver. 
Conversion of parathlon to paraoxon in the 40.4 and 52.8 ppm level 
trials produced skewed Llneweaver-Burk plots. Figure 13 illustrates plots 
for the two levels. These plots are consistent with that described by 
Winkler et al. (1974) for natural substrates (vide Figure 3, page 22 of 
this dissertation), in which higher substrate concentrations skewed the 
linearity present at lower concentrations. 
Figure 13. Lineweaver-Bxirk plots of parathion conversion to paraoxon 
A. After addition of 52.8 ppm parathion to a liver per­
fusion preparation 
5. The same plot after addition of 40.4 ppm parathion to 
a liver perfusion preparation 
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V. DISCUSSION 
This study involved the use of two tissues, incorporating their com­
patibility and exchange relationships. Blood perfusate and liver inde­
pendently exerted influences on the availability and metabolism of para­
thion and its metabolites. In addition, blood and liver interactions 
influenced the transfer and depot storage characteristics of parathion and 
its metabolites in these tissues. These intricate influences are embodied 
in compartmental analysis and transhepatic exchange phenomena of the types 
defined by Skinner et al. (1959), Goresky (1974) and Forker et al. (1978), 
and also the Michaelis-Menten parameters of saturation kinetics defined by 
Winkler et al. (1974) and Keiding (1976). These phenomena are the cri­
teria by which the mechanisms of detoxification under physiologic condi­
tions are precisely described. Such avenues have been explored in the 
elucidation of drug and natural compound clearances, but not for insecti­
cides. This study was a preliminary investigation into hepatic uptake and 
clearance of parathion in the presence of homologous blood. 
14 
The distribution of C in components of the perfusion system was 
present in the order of blood > liver > bile (39.9% > 18.9% > 0.6% re­
spectively; values are averages of three trials). A similar distribution 
was obtained by Fuhremann et al. (1974), with the major differences exist­
ing in binding to the system's hardware and in the liver. The sum of 
14 
C system-bound and recovered in the blood perfusate of this study equals 
14 
the C perfusate level obtained by Fuhremann et al. (1974) using an 
artificial ionic perfusate. The presence of blood binding components in 
this study may account for the system binding discrepancy, since blood 
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lipoprotein/parathion complexes are highly polar and subject to binding to 
hardware materials as substrates. The contention by Fuhremann et al. that 
system binding in blank (without liver) runs was eliminated in test (with 
liver) runs due to formation of water soluble metabolites is rather, in 
the present study, a condition of blood protein binding followed by system 
binding. An observed plasma protein plaque lining the perfusion plumbing 
lines was evidence for loss from circulating perfusate. 
Of the total 39.9% recovered from input concentrations of 40.4-
52.8 ppm in the system's blood at 60 min (vide Figure 9, page 64), its 
distribution between plasma and red cell components was proportionately 
0.8 to 0.2 respectively. These proportions are in agreement with those 
obtained by Schoenig (1975). In addition, the degree of parathion binding 
to blood (35.2%) determined in the preliminary investigation in Figure 5B, 
page 51, agrees with Schoenig's value of plasma-bound after ^^C-
parathion incubation with rat blood. 
Parathion recoveries from liver and blood at 60 min post-addition to 
the perfusion system averaged 0.61% and 3.26% of the added quantity re­
spectively for the four 60 minute trials. The low liver:blood parathion 
ratio (0.2) suggests that the liver does not store free parathion. It 
may be that parathion is largely converted to metabolites which were con-
14 
tained in the liver at sampling time. In addition, the liver:blood C 
14 
ratio was 0.47. A greater proportion of C than parathion in the liver 
supports the notion that the liver contained metabolic products of para­
thion. Total parathion plus paraoxon recovered from blood was 7.6%. 
Values obtained by Fuhremann et al. (1974) are considerably higher, and 
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this may be due to the absence of blood binding and system binding compo­
nents mentioned earlier, resulting in increases in extractable parathion 
and paraoxon. Clearly, blood binding is an important influential inter­
mediary between parathion and paraoxon uptake, metabolism and subsequent 
recovery. 
Free parathion in blood perfusate depleted quickly, free paraoxon 
levels appeai'ed rapidly and remained fairly steady according to Figure 10, 
page 65, and Figure 11, page 67. If the degree of blood binding of para­
thion from 0-60 min were as indicated in Figure 3B, page 51 (100% -
64.8% = 35.2%) for the parathion concentration in the perfusate at any 
given time, then the actual values presented in Figure 10 would be ele­
vated by 35.2%. Similarly, if paraoxon binding from 0-60 min were as 
indicated for the 8.5 ppm level in Figure 5C (100% - 79% = 21%) for the 
paraoxon concentration at any given time, then the paraoxon values in 
Figure 11 would be elevated by 21%. 
Paraoxon levels obtained in the 60-minute trials (ranging from 2.5% 
to 17.0% of the injected parathion dose) were intermediate between the 
higher values obtained by Fuhremann et al. (1974) using an artificial 
medium for perfusate in a rat liver preparation, and the absence of para­
oxon obtained by Schoenig (1975) with whole blood in an vivo rat study. 
Schoenig suggested that plasma protein binding functioned as a buffer 
against paraoxon toxicity by its binding to the proteins, and that a buf­
fering capacity is attained at which paraoxon binding is at a maximum, 
above which it is freely dissolved in plasma. The constant titer in the 
blood from 20-60 min post-addition (corresponding to an average of 1.2 ppm 
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and 4.2 ppm for the two trials in which paraoxon was detected) does not 
necessarily indicate that at these levels of detection the buffering 
capacity of plasma proteins had been reached. Rather, because a constant 
amount of paraoxon was extractable (and therefore in its free form), what 
is suggested is a dynamic equilibrium between free and bound paraoxon, 
resulting in a constant amount of free paraoxon always present in the 
blood, independent of proximity to the buffering capacity and paraoxon 
blood concentration over the range appearing in this study. This level is 
in turn regulated by paraoxon metabolism to diethyl phosphoric acid and 
2-nitrophenol. The difference in paraoxon levels obtained by Schoenig 
from those of this study may be due to the differences in dose levels and 
routes of entry into the blood. Schoenig incorporated gastrointestinal 
absorption to produce in vivo blood levels of 0.04 ppm parathion in rats 
2 hours after a 6 mg/kg dose. This study involved adding 40 ppm parathion 
directly to the blood via the reservoir. In addition, this study utilized 
a pig liver metabolizing mass 400 times greater in weight than the rat 
liver and eliminated the effects of other tissues. Although no free pr 
nltrophenol was detected in the presence of the artificial perfustate used 
by Fuhremann et al. (1974), it was suggested that ^ r^itrophenol in conju­
gated form was present as a result of paraoxon metabolism by the liver. 
The presence of a paraoxonase type of arylesterase has been demonstrated 
to exist in blood (Mendoza et al., 1977), indicating that paraoxon metabo­
lism may, in part, take place in the blood. The free paraoxon concentra­
tions (1.2 ppm and 4.2 ppm for the 40.4 ppm and 52.8 ppm dose levels) are 
significant in terms of target site toxicity. Schoenig (1975) has 
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suggested that as little as 0.75 ppm paraoxon in the blood may be suffi­
cient to cause a toxic reaction. 
The importance of the buffering effects of other body tissues and the 
gastrointestinal tract's ability to reduce the dose slug effect by limit­
ing absorption into the bloodstream must not be overlooked. Addition of 
parathion directly to the circulating blood as a pulsatile dose is equiva­
lent to rapid intravenous injection of the entire dose into a living sub­
ject. The blood levels subsequently obtained in this study were much 
higher than those of Schoenig (1975), who incorporated the gastrointestin­
al tract barrier and extrahepatic tissue removal in an vivo study. 
Values for first pass absorption of parathion by the liver were very 
high (vide Figure 8, page 62) and consistent with the value obtained by 
Schoenig (1975), who gauged the actual hepatic share of parathion uptake 
and metabolism to be greater than 75% of the quantity passing through the 
portal vein. The ability of the liver to extract a huge quantity of para­
thion during its first encounter is the most protective of all mechanisms 
designed to reduce the body's exposure. Although this is superseded to a 
degree by the liver's subsequent production of the more potent paraoxon, 
this is counteracted by protective parac.ron binding and further metabo­
lism to polar extractables. As another protective mechanism, the liver 
bypasses paraoxon formation to a degree by shunting parathion into a 
metabolic pathway producing diethyl phosphorothioic acid and 
phenol. The toxicity of parathion lies in the high degree of potency of 
paraoxon. 
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The protective mechanism of massive liver absorption broke down or 
reversed slightly on second pass (vide Figure 8, page 62), since the 
quantity of parathion in the blood either remained the same or increased 
slightly. The reappearance of parathion in the blood may have been a re­
sult of returning material from the liver, since first pass engorgement of 
hepatocytes with parathion due to massive uptake was beyond the liver's 
ability to sequester it.^ This is further supported by the nature of low 
density lipoprotein binding to pig liver membranes (Bachorik et al., 
1976). The binding mechanism, linear with increasing pig liver plasma 
membrane concentrations up to 1 mg/ml, involves lipid and apoprotein 
moieties. A specific membrane-lipoprotein interaction occurs, and al­
though lipoprotein affinity for the membrane is high, the binding 
phenomenon is saturable due to the limited number of binding sites and 
competition by lipoproteins of higher densities. The saturable nature of 
liver membrane binding would cause low-density lipoprotein-bound parathion 
to reappear in the blood beyond saturation point. 
The presence of liver paraoxon in extractable quantities less than in 
blood (vide Figure 12, page 69) suggests that the liver (1) dumped para-
oxon into the blood stream rather than store it or (2) bound the majority 
of liver paraoxon to an tmextractable form. Subsequent metabolism of 
paraoxon to 2;-nitrophenol and diethyl phosphoric acid following blood 
dumping would have first required paraoxon reuptake by the liver. 
^max Che parathion to paraoxon conversion is very high in rela­
tion to Kjh. Therefore, the metabolic conversion process is saturated at 
low parathion levels. See further discussion on page 79. 
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Skewed Lineweaver-Bxirk plots for the parathion to paraoxon conversion 
were obtained for the two trials in which paraoxon was detected. These 
were similar to that described by Winkler et al. (1974), although the 
plots are preliminary in their description of Michaelis-Menten kinetics, 
since blood, liver and system binding were not accommodated in their 
preparation. Skewing precluded the determination of and values. 
In whole organ preparations, Michaelis-Menten kinetic constant determina­
tions require the knowledge of the average sinusoidal concentration of 
parathion if V /K is not small in relation to flow (Keiding, 1976). 
max m 
Otherwise, the input portal concentration may be used. Porcine values of 
10.28 X 10 ^  M and 0.51 nmol/min/mg protein for and respectively 
(Whitehouse and Ecobichon, 1975) produced a V /K value of 4961 for a 
max m 
microsomal study of the parathion to paraoxon conversion. This is much 
greater than the flow used in the present study, and to determine and 
^max therefore would have required that liver biopsy specimens be taken 
during the course of experimentation to obtain parathion contents. Such 
determinations with other compounds have resulted in higher K and V 
m max 
values than those determined in homogenate studies. 
The stasis condition of the liver is very important to its effects 
on parathion. Certain observations regarding the condition of the liver 
and the influence of noninsectlcide materials on the organ's performance 
are noteworthy. The three most important indicators of a good perfu­
sion preparation were considered to be high blood flow, rapid resumption 
of bile flow and no swelling or discoloration of the liver. The period of 
ischemia was well within the 30 minute time limit beyond which irreversi­
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ble effects occur (Battersby et al., 1974). Yet while blood and bile flow 
rates v<^re considered to be adequate, swelling and discoloration did 
occur. Swelling seemed to be unavoidable and has been reported as a 
necessary condition of pig liver perfusion (Van Wyk et al., 1966). At 
hepatic venous pressures of -5 to 0 mm Eg, swelling ranged from -12% to 
42% in the present study (vide liver weight gains in Table 1, pages 53-
54). These venous pressures were nevertheless correct for achieving 
optimal liver function, since hepatic venous outflow resistance is re­
quired to produce sinusoidal distention aad subsequent maximum hepatocyte/ 
blood contact through which normal liver functions are maintained. This 
sinusoidal distention is in turn manifested in liver swelling (compliance) 
which is a normal consequence of liver morphology and design. The pig 
liver is able to double its empty weight with maximum distention (Wood 
et al., 1967). 
Discoloration of the liver periphery to a deeper purple than observed 
during surgery occurred throughout perfusion in all trials. This was 
attributed to peripheral vasoconstriction, since upon dissection, the 
lobar cores were lighter in color. This further was not a consequence of 
nonperfusion of the hepatic artery, since (1) distributing veins form 
bridges between the portal and arterial blood supplies, so that areas of 
the liver serviced by the hepatic artery still have blood contact (Elias, 
1953) and (2) hepatocellular necrosis due to hepatic arterial ligation has 
been demonstrated not to occur (Morrow et al., 1976). 
The liver chamber design and tilt accommodated the formation and 
recollection of ascites fluid by the system. At venous outflow pressures 
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of -5 to 0 mm Hg, van Wyk et al. (1966) reported ascites fluid production 
of 28-46 ml/5 min. Although not measured, comparable quantities of 
ascites were produced in the present study and shunted back into the 
systemic circulation of the perfusion system via the reservoir. In vivo, 
ascites fluid secreted through the liver capsule is drained by the 
thoracic lymph duct and right lymph trunk. Similarly, lymphatic drainage 
of the hepatic parenchyma occurs through channels running to the thoracic 
duct. Returning this fluid to the perfusion system was carried out to 
maintain a steady fluid balance, hematocrit and osmotic balance. 
Any study involving isolated perfusion preparations necessitates the 
use of anesthetic during liver removal. The question arises as to 
whether halothane anesthesia will have subsequent effects on parathion 
manipulation by the isolated liver. Histotoxicity is one of the major 
implications of halothane metabolism, and although attention has focused 
on its toxicity and metabolism, the toxicity/metabolism relationship is 
not yet clear. Halothane is metabolized 60-70%, predominantly to tri-
fluoroacetic acid at high oxygen tension (Dallmeier and Henschler, 1977; 
van Dyke and Gandolfi, 1976). At low oxygen tension it undergoes cyto­
chrome and NADPH-dependent reductive defluorination, with binding of 
defluorinated compound to microsomal phospholipids. There are dramatic 
effects of prolonged halothane anesthesia on blood (increased lactic acid, 
increased whole body oxygen consumption, respiratory and metabolic acido­
sis, increased catecholamines, increased temperature due to hyperthyroid 
activity, decreased hepatic flow due to increased hepatic vasomotor tone) 
(Berger et al., 1976; Cowan et al., 1975; Gronert and Theye, 1976). These 
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effects are inconsequential in the present study because of the short 
halothane exposure time (36±10 min) and use of halothane-unexposed blood 
in the perfusion system. 
Liver cell damage after halothane exposure has been noted by an in­
creased serum bilirubin and transferase levels (Johnstone et al., 1976). 
The actual events occurring In the liver cells have been extensively re­
viewed (Berman et al., 1975; Schulte-Herman, 1974). Although the main 
effects of halothane on the liver are exerted extrami crosomally, those 
effects directly related to microsomal metabolism are (1) proliferation of 
the smooth endoplasmic reticulum and corresponding Increase in microsomal 
redox enzymes, (2) a shift of cytochrome b^ to the oxidized fom, (3) in­
creased consumption of NADPH and oxygen to elevate the NADPHrNADP ratio 
and (4) Increased enzymes of intermediary metabolism in proportion to an 
Increase in liver size. These effects are produced more quickly by tri-
fluoroacetic acid, indicating that the conversion of halothane to tri-
fluoroacetlc acid is an activation reaction. Under the conditions of 
liver retrieval and experimentation in this study, the effects of halo­
thane on microsomal enzyme Induction and subsequent parathlon uptake and 
metabolism were substantially minimized. 
This investigation suggests that parathlon manipulation will follow 
the same distributive pathway and rate of heaptlc clearance as suggested 
by other researchers for natural compounds and drugs. Further research 
with respect to quantitation of parameters defining insecticide distribu­
tive pathways and rate of clearance are needed to define more clearly 
their toxicity. 
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VI. SUMMARY AND CONCLUSIONS 
Preliminary investigations into the recovery of parathion from saline 
revealed an extraction efficiency of 83-103% for concentrations of 
9.7-29.1 ppm after 18 hours of storage at 4®C. Similar studies with 
parathion in whole pig's blood resulted in 64.8% and 67.8% recoveries 
at 37*C and 4*C, respectively, after 60-minute incubations of 41.2 ppm 
and 18 hours of storage. Paraoxon recovery from blood after 18 hours 
of storage at 4°C was 52.0% for 17.0 ppm and 25.5 ppm, and 78.0% for 
8.5 ppm. 
Venous outflow profiles of parathion from ^  vivo blood perfused pig 
livers on first pass followed existing principles of transsinusoidal 
51 
exchange for Cr-labeled red blood cells and test compounds subject 
to hepatic sequestration. First pass absorptions of parathion by the 
liver for input concentrations of 33.9, 41.0 and 52.8 ppm were 97.8, 
84.5 and 68.7% respectively. Cumulative parathion absorption by the 
liver at second pass leveled off or declined slightly, indicating re­
turn of parathion from liver to blood. 
14 
After 60 minutes of perfusion, C-parathion levels in perfusate blood 
were reduced to less than 12% of initial concentrations ranging from 
40.2-52.8 ppm. Average blood levels of parathion and paraoxon in four 
trials were 3.26% and 4.32% respectively; average liver values were 
0.61% and 3.22%. No ^ -^Crophenol was detected in liver or blood. 
14 
C was distributed 39.9% in blood (mainly in the plasma component), 
18.9% in liver and less than 0.6% in bile. 
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Lineweaver-Burk plots of the parathion to paraoxon conversion were 
skewed, precluding the determination of and values. 
Binding of parathion to blood constituents was a critical determinant 
of parathion behavior in the blood-perfused, ex vivo pig liver. Free 
parathion disappeared rapidly due to hepatic uptake and blood binding. 
Free paraoxon in blood was maintained at a steady titer in sufficient 
quantities to produce vivo toxicity. The kinetics of the parathion 
to paraoxon conversion did not follow typical Michaelis-Menten satura­
tion phenomena due to the introduction of the three dimensional compo­
nent of a whole organ. A need was demonstrated for the determination 
of compartmental distribution, more detailed assessment of kinetic 
parameters of metabolism and transsinusoidal exchange characteristics 
of insecticides in the whole liver preparation. 
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